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ABSTRACT
Atopic dermatitis (AD) is an inflammatory skin disease whose pathogenic
mechanisms remain unclear. Using a validated human AD-like mouse model, we
observed that skin remodeling started at a pre-symptomatic stage of AD that
included cellular infiltration of the hypodermis, accompanied with
activated/degranulated mast cells (MC). Local MC activation was quantified using
a novel method of computer-assisted image analysis we developed and reported.
Using a variation of this method, we defined morphometric parameters allowing
for quantitation rather than scoring of cellular infiltration. Cell recruitment
correlated with MC activation, chemokine production and increased levels of
sphingolipid sphingosine-1-phosphate (S1P), produced by sphingosine kinase-1
(SphK1). MC or SphK1 deficiency significantly hindered early AD inflammation.
Chronic AD features skin barrier dysfunction leading to skin lesions due to
decreased lipid ceramide (CER) content. Interestingly, local CER species C16
and C24 were significantly increased in pre-symptomatic AD. Accordingly, skin
CER synthase (CerS, CER synthesis) CerS4, 5 and 6 mRNA mRNA levels were
statistically augmented. Because of the overall proapoptotic functions of CER, we
next measured local cleaved/activated caspase 3 levels, the executioner
caspase in apoptosis. Skin cleaved caspase 3/apoptosis was significantly
augmented in early AD and correlated with increased endoplasmic reticulum
(ER) stress-related molecular players. To substantiate the importance of MC in
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ER stress-induced apoptosis, CER profiling was similarly conducted in treated
skin samples collected from MC-deficient mice. MC deficiency prevented CER
increase and local apoptosis that were restored following MC reconstitution.
Epigenetic regulation of the molecular pathways that drive AD is unknown.
We identified and validated a microRNA triad 34a-485-486 whose
downregulation promoted the AD-related pathogenic pathways we have
unraveled.
We conclude that MC may initiate AD by driving early skin remodeling and
cell recruitment through local chemokine and S1P production and CER-elicited
apoptosis. Moreover, the down-regulation of a miRNA triad de-represses these
key players of AD pathogenesis. Targeting these pre-symptomatic effector
mechanisms may offer new prophylactic strategies for AD whose treatment
remains a clinical challenge.
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FOREWORD
Mast cells are immune cells of hematopoietic lineage. Differentiation and
maturation of MC occurs as they reach the vascularized tissues where they will
reside (Kitamura, 1989). MC exist as two distinct subsets, distinguishable by the
protease composition of secretory granules. In humans, MCTC contain tryptase,
chymase, and other proteases, while MCT contain only tryptase (Oskeritzian et
al., 2005). MCTC (equivalent to connective tissue MC, CTMC) are located in the
skin, heart, muscle, and submucosa of the small intestines while MCT (equivalent
to mucosal MC, MMC) are localized to airway epithelia and small intestine
mucosa (Schwartz, 2005).
MC, uniquely identified by dual expression of c-kit, stem cell factor (SCF)
receptor, and high affinity immunoglobulin (Ig) E receptor (FcεRI), are key
effector cells of IgE-mediated immune responses, including allergic diseases.
IgE-dependent MC activation occurs following antigen (Ag) cross-linking of
surface-bound IgE, triggering the release of many mediators. Some mediators,
such as vasoactive amines (e.g. histamine), neutral proteases (e.g. tryptases and
chymases), proteoglycans (e.g. heparin) some cytokines and growth factors and
sphingolipid S1P are pre-stored within MC and released immediately upon
activation, while prostaglandins, leukotrienes and other pro-inflammatory lipid
mediators are produced de novo. In addition, MC can secrete a wide variety of
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growth factors, cytokines, and chemokines in response to various stimuli in a
tissue and/or species-dependent manner (Galli et al., 2015).
Human MC and mouse bone marrow-derived MC (BMMC) are important
tools for analyzing MC responses in vitro. Primary MC can be isolated from
tissues and expanded ex vivo in the presence of MC-specific growth factors,
which include SCF (and interleukin (IL)-3 for mouse MC). In addition, MC lines
are available. The most common MC lines are rat basophilic leukemia (RBL)-2H3
cells, human HMC-1 and LAD2 cells, derived from patients with MC leukemia
(Butterfield et al., 1988; Kirshenbaum et al., 2003), and commercially available
LUVA cells, that spontaneously developed from human blood CD34+ cells
(Laidlaw et al., 2011). While convenient, cell lines present transformed
phenotypes with constitutively activated signaling pathways, making primary cells
preferable for studying MC functions in vitro.
MC-deficient mice have proven useful for studying the relevance of MC in
health and disease. Kit, receptor for stem cell factor (SCF, previously called MC
growth factor), is expressed on all hematopoietic stem cells. While most cells
gradually lose Kit expression as they mature, MC remain Kit+. Kit W/W-v and Kit Wsh/W-sh MC-deficient

mice feature c-kit mutations. Kit W-sh/W-sh mice present fewer

abnormalities than Kit W/W-v mice, which are anemic and difficult to breed. In
addition, Kit W/W-v mice display other phenotypic abnormalities including
decreased numbers of TCRγδ and spontaneous dermatitis, thus Kit W-sh/W-sh mice
are preferred (Grimbaldeston et al., 2005). Nonetheless, mutations in Kit may
alter other cells than MC. To avoid the collateral issues related to c-kit mutations,
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alternative MC-deficient mice were generated, in which Cre recombinase (Cre) is
expressed under the control of “MC-restricted” promoters. The mast cell protease
(Mcpt) 5-Cre; R-DTA mice feature diphtheria toxin alpha (DTA)-induced deletion
of CTMC only and have an otherwise normal immune system (Dudeck et al.,
2011). Cpa3Cre/+, or “Cre-Master”, mice display a carboxypeptidase A3 (Cpa3)directed activation of Cre, which results in eradication of all MC, but also affects
some T cell populations and basophils (Feyerabend et al., 2011). Cpa3-Cre;Mcl1fl/fl, affectionately called “Hello Kitty” mice by Dr. Steve Galli who generated
them, are similar to the Cpa3Cre/+strain as constitutive reduction in all MC is
observed with concomitant depletion of basophils (Lilla et al., 2011). Perhaps
more clinically relevant than MC-deficient models, another approach has been to
induce MC ablation when desired. To this end, Mcpt5-Cre;iDTR mice (Dudeck et
al., 2011), “Mas-TRECK mice (Otsuka et al., 2011; Sawaguchi et al., 2012), and
Cpa3-Cre;iDTR mice (Reber et al., 2014) are all inducible models of MC
depletion (Galli et al., 2015). To confirm the importance of MC to a specific
disease state, MC-deficient mice can be conveniently reconstituted through
adoptive transfer of BMMC from WT or knockout mice of similar C57Bl/6 genetic
background.
Sphingosine-1-phosphate (S1P) is a potent sphingolipid metabolite
important for cell trafficking, proliferation and survival responses. The pleiotropic
properties of S1P can be attributed to the fact that S1P can bind to 5 specific G
protein-coupled receptors, termed S1P receptors (S1PR1-5), expressed in
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various combinations by a variety of different cell types, including T and B cell
lymphocytes, dendritic cells and mast cells (Spiegel and Milstien, 2011).
MC can produce S1P both constitutively and upon IgE/Ag activation,
which concomitantly activates SphK (Oskeritzian et al., 2008) that phosphorylate
sphingosine to produce S1P. The two isoforms of SphK have distinct functions in
MC. SphK2 is most important for production of S1P in the nucleus and other
subcellular compartments, while SphK1-derived S1P may be transported outside
of the cell to ligate cell surface S1PR in an autocrine and/or paracrine manner
(Mitra et al., 2006; Oskeritzian et al., 2008). MC express S1PR1, which plays a
role in immune cell trafficking and migration, and S1PR2, which stops movement
mediated by S1PR1 and triggers release of MC granules (Jolly et al., 2004;
Spiegel and Milstien, 2011).
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CHAPTER 1: INTRODUCTION
1.1 MAST CELLS AND SPHINGOSINE-1-PHOSPHATE IN EARLY ALLERGIC
LUNG INFLAMMATION
We recently demonstrated the importance of MC/S1P signaling, through
S1PR2, for early T cell recruitment to inflamed lungs in a model of passive
systemic anaphylaxis (PSA) (Oskeritzian et al., 2015). Mice were passively
sensitized with IgE anti-2,4-dinitrophenyl (DNP) and later challenged with antigen
(Ag) DNP-human serum albumin (DNP-HSA). We found that the neutralization of
extracellular S1P with a specific anti-S1P mAb (SphingomabTM), prior to Ag
challenge, resulted in significantly decreased levels of circulating histamine,
monocyte chemoattractant protein 1 (MCP-1)/CCL2), macrophage inflammatory
protein 1α (MIP-1α)/CCL3 and RANTES/CCL5 compared to an isotype-matched
negative control Ab. We established that these chemokines were important for
CD3+ T cell recruitment. Moreover, we identified MC as a local source of CCL2
and CCL5. Significantly reduced levels of circulating chemokines were detected
in MC-deficient Kit W-sh/W-sh mice following Ag challenge, compared to WT
controls. Furthermore, when MC-deficient mice were reconstituted with MC by
adoptive transfer of BMMC, production of circulating chemokines observed in WT
mice was restored. Following Ag challenge, Sphingomab recipients and MCdeficient mice were protected from the drastic drop in core body temperature
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indicative of anaphylaxis and early pulmonary edema observed in isotype or WT
controls. These results highlighted MC/S1P axis as a major contributor of tissue
remodeling during the early phase of allergic responses in the lungs and were
publicized as the Editor’s Choice of The Journal of Allergy and Clinical
Immunology and again as a part of the “Advances and highlights in mechanisms
of allergic disease in 2015” (Wawrzyniak et al., 2016).

1.2 ATOPIC DERMATITIS
Atopic dermatitis (AD) is a recurring inflammatory skin disease which
affects 10-25% of individuals residing in developed countries. Primarily starting in
early childhood, 85% of patients experience onset of symptoms prior to age 5.
Individuals affected with AD often develop other allergic disorders, such as
asthma, food allergies or rhinitis later in life, making it the first manifestation of
allergies in what has become known as the atopic march. AD occurrence has
increased in recent years, but is less prevalent in rural areas supporting the
“hygiene hypothesis” which states that early exposure to infectious agents aids
immune system development and decreases susceptibility to allergic (and
autoimmune) disease (Bieber, 2010).
AD pathogenesis has been attributed to Ag penetration through a
compromised barrier, which triggers activation of skin resident cells and release
of many pro-inflammatory mediators, leading to severe itchiness, dry-flaky skin
and lesions. AD skin displays thickening of the epidermis and dermis layers
accompanied by accumulation of immune cells (Bieber, 2010; Yoon et al., 2016),
including effector T cell subsets (Th1, Th2, Th17 and Th22) and MC (Auriemma
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et al., 2013; Werfel et al., 2016). Molecularly, inflammatory pathways of AD are
biphasic. The acute phase is thought to be driven by Th2 cells whereas Th1
immune responses dominate chronic lesions (Bieber, 2010). Observations of
chronic inflammation associated with AD has prompted many studies, resulting in
suggested potential targets for therapeutic intervention, including cytokines and
chemokines present once the disease has developed. Available treatment
options, for moderate to severe AD, consist in symptom management with
undesirable side effects such as diabetes, hypertension, gastric ulcers,
osteoporosis, glaucoma, growth retardation, renal toxicity, liver dysfunction and
leukopenia (Simon and Bieber, 2014).
For mild AD, moisturizers can contribute to restoration of the skin barrier.
Many of these topical skin care products feature addition of the sphingolipid
ceramide (CER), critical for maintaining barrier functions in healthy individuals.
AD patients present a loss of very long chain ceramides that compose the
stratum corneum (SC) layer of epidermis. It has been thought that adding
ceramides to moisturizer would positively affect SC structure and lipid
organization. However, a recent study, comparing efficacy of ceramide-rich
moisturizer on AD patients, found no significant difference in disease severity
when compared with other moisturizing products (Miller et al., 2011).
Inflammation results from the coordinated actions of diverse molecular
pathways driving a variety of altered gene and protein expression. The discovery
of miRNA, small noncoding molecules that control translation of target mRNA
and therefore post-transcriptionally fine-tune many biological processes, has
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prompted new lines of research to better understand AD etiology (Plank et al.,
2013). Sonkoly et al. were the first to conduct a genome-wide analysis of miRNA
expression in human biopsies of healthy, psoriatic and AD skin samples but were
ultimately unable to define an AD-specific signature (Sonkoly et al., 2007). In a
later study, they linked overexpression of miR-155, which targets cytotoxic T
lymphocyte–associated antigen 4 (CTLA-4), to increased proliferation of TH cells
in AD (Sonkoly et al., 2010). More recently, Rebane et al. reported that miRNA
146a is upregulated in keratinocytes from chronic lesions of AD patients,
contributing to suppression of innate immune responses (Rebane et al., 2014).
However, there is no study defining the miRNA signature of AD pathogenesis.

1.3 STATEMENT OF HYPOTHESIS AND AIMS
Allergenic stimulation releases the multifaceted sphingolipid S1P from
tissue-resident MC (Mitra et al., 2006; Oskeritzian et al., 2008; Oskeritzian et al.,
2010). Our most recent studies revealed that S1P serves to further propagate
inflammatory responses through autocrine/paracrine stimulation of MC, creating
an inflammatory amplification loop, which we have shown is essential to the
onset of acute pulmonary inflammation As MC are present in normal skin at
homeostasis and they become more numerous and activated in inflamed skin
(Bieber, 2010; Liu et al., 2011), we suggest a similar critical role for MC and S1P
in the onset and progression of skin inflammation. We are proposing to establish
the contribution of MC in diseased mouse skin samples, compared to healthy
skins, at the initiation of AD. We anticipate an early-defined MC-driven molecular
signature at AD onset that may allow for the design of new prophylactic
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strategies to prevent further disease development. Next, we propose local S1P
plays a key role in inflammatory cell recruitment through its stimulatory effects on
MC degranulation, likely propagating inflammation. Moreover, since AD is
associated with loss of skin barrier functions and because lesional skin of AD
patients displays decreased ceramide content, we will investigate changes in
CER levels at early-phase skin inflammation, a time-point which may be more
receptive to repair strategies. As little is known pertaining to the epigenetic
regulation of AD by miRNAs, we also propose to investigate miRNA expression
during AD pathogenesis.
For this study, we designed the following aims:
•

Aim 1: Establish the molecular mechanisms underlying early skin
remodeling at the onset of AD

•

Aim 2: Examine how S1P and MC contribute to skin inflammation in earlyphase AD

•

Aim 3: Investigate ceramide species at the initiation of AD

•

Aim 4: Define the regulatory function of miRNA in AD development and
progression

To study the direct implication of MC during AD inception, we first developed a
computer-automated system to measure MC activation status in situ.
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CHAPTER 2: A NEW IMAGE ANALYSIS METHOD BASED ON MORPHOMETRIC
AND FRACTAL PARAMETERS FOR RAPID EVALUATION OF IN SITU

MAMMALIAN MAST CELL STATUS1
2.1 INTRODUCTION
Mast cells (MC) are long-lived tissue-dwelling cells, found in all
vascularized tissues at homeostasis, especially at the host/environment
interfaces, including skin, airways and the gastrointestinal and genitourinary
tracts (Galli et al., 2011). There is mounting evidence that MC manifest
substantial immunomodulatory functions in many physiological processes
through the vast repertoire of mediators they release upon activation (Galli et al.,
2011; Oskeritzian, 2015). Degranulation represents the canonical process
through which activated MC secrete mediators (Wernersson and Pejler, 2014). It
refers to rapid exocytosis of granules that occupy about 80% of MC cytoplasm
and harbor a wide array of preformed bio-active substances (Galli and Tsai,
2012; Moon et al., 2014). A spectrum of receptor-dependent and independent
stimuli can activate MC, including physical and mechanical triggers, and the

1

Wedman, P., A. Aladhami, M. Beste, M.K. Edwards, A. Chumanevich, J.W. Fuseler, and
C.A. Oskeritzian. 2015. A New Image Analysis Method Based on Morphometric and
Fractal Parameters for Rapid Evaluation of In Situ Mammalian Mast Cell Status. Microsc
Microanal 21:1573-1581.
Reprinted here with permission of publisher.
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subsequent secretion of histamine, proteases, lipid mediators, cytokines, and
chemokines (da Silva et al., 2014). To date, investigators are taking advantage of
MC cytoplasm replete withgranules as intragranular proteoglycans interact with
metachromatic dyes such as methylene blue (MB) to allow for visualization,
anatomical distribution and enumeration of MC in tissue sections (Wolters et al.,
2005). The interaction of these highly sulphated structures with dye molecules
yields a distinct blue/purple color uniquely staining MC cytoplasmic granules
(Lagunoff, 1974; Wolters et al., 2005). Other commonly used histological
methods include chloroacetate esterase, but this technique may also stain
granulocytes (Rafail et al., 2015). Although local MC identiﬁcation may be
straightforward, microscopic discrimination between intact and degranulated MC
could be daunting even for trained observers as tissue MC are polymorphic and
staining intensity may vary even when routinely used. Thus, the universally
accepted method to substantiate MC activation remains circulating level
determination of MC-restricted mediators, including tryptase (Schwartz et al.,
1987). However, while unequivocally quantitative, systemic measurements do
not reﬂect in situ alterations of MC. Because of their strategic location, MC can
regulate vascular permeability and cell recruitment to initiate local inﬂammation,
therefore exerting important pathogenic functions (Marshall, 2004). We reasoned
that image analysis could aid to develop a reproducible, objective and thus
reliable method to quantify rather than score MC activation. To this end, we
investigated normal mouse skin samples for MC using the well-established MB
staining of tissue sections. Images of a large number of MC were captured from
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four different mice. Next, we considered MC granule-ﬁlled cytoplasm as an object
and MC as regions of interest (ROI), endowed with size, volume and staining
intensity parameters. We reasoned that an intact MC should feature higher
values for these parameters, compared to degranulated MC. Our results
demonstrate these morphometric parameters precisely classify MC into two
objective groups, intact and degranulated MC. We further complemented these
measurements by quantiﬁcation of fractal dimension values for each cellular
state. Taken together, we have established a rigorous analytical method based
on acquisition of morphometric data collected from digitized images of tissue
sections that allows for reliable and objective quantitation of MC activation status.
Thus, MC disorders may involve aberrant proliferation of MC exempliﬁed by
mastocytosis, a myeloproliferative neoplasm, but many primary MC diseases
feature normal MC numbers of abnormal hyperactivity (Hamilton et al., 2011;
Valent et al., 2011). Chronic MC activation could be challenging to diagnose,
often accompanied with mild, episodic or atypical symptoms of idiopathic origin
(Valent et al., 2011). Based on our study, pathological specimens could be
surveyed for MC status at a greater scale for diagnostic/prognostic purposes in
MC related disorders or in diseases where MC dysfunction is suspected in the
absence of pathognomonic signs.

2.2 MATERIALS AND METHODS
Reagents
All chemicals were purchased from Fisher Scientiﬁc (Pittsburgh, PA,
USA).
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Animals
Gender- and aged- matched C57BL/6 mice were purchased from Charles
River NCI (Frederick, MD, USA). All mice were used at 8–12 weeks of age and
maintained in a pathogen-free facility. Studies were performed in accordance
with institutional animal care and use committee guidelines.
Histology
For skin tissue collection, mice were euthanized by CO2 asphyxiation. The
skin from the dorsal back was shaved. Skin samples were collected and ﬁxed in
10 %-buffered formalin. Fixed tissues were embedded in parafﬁn, sectioned (5
μm thickness) and mounted on microscope slides. Some slides were stained with
hematoxylin and eosin. Other slides were de-parafﬁnized in xylene, hydrated
through graded alcohols, and equilibrated in phosphate-buffered saline. To
visualize MC, slides were placed in 0.1 % methylene blue (MB) for 5 s, rinsed
with water, dehydrated in 100 % ethanol and mounted under coverslips with
cytoseal 60 (Wolters et al., 2005). Sections were imaged with a Nikon E-600
microscope (Nikon Inc., Melville, NY, USA) equipped with a Micropublisher digital
camera and images collected with 10× and 40× objectives. Fourteen adjacent
images were recorded from each section as TIFF ﬁles. Morphometric parameters
of MC were measured using the MetaMorph® 6.1 Microscopy Automation and
Image Analysis software (MolecularDevices, Sunnyvale, CA, USA).
Descriptors of MC Morphology in the Skin
The morphometric descriptors of area (A), integrated optical density (IOD)
to generate relative density (IOD/A), and fractal dimension (D) were measured
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for thresholded and isolated MC residing in the hypodermis and dermis of
isolated regions of the skin (n = 4 mice).
Isolation and Area of MC
In the hypodermis and dermis of digitized images, MC were isolated as
individual ROI using the hue, saturation, intensity (HSI) color model of the set
color threshold subroutine of MetaMorph 6.1 software. The area of the cell
measured excluded holes (non-stained regions) within the ROI.
IOD of MB-stained MC
The HSI values were adjusted to isolate the blue/purple metachromatic
color characteristic of MC as a thresholded region. The cytoplasmic blue/purple
metachromatic color distinguishes MC from other blue staining in the tissue.
From the thresholded region, the area (A) of the cell and its IOD were measured
using the integrated morphometry subroutine of MetaMorph 6.1. The image of
the individual isolated MC was converted to a gray scale image for further
analysis of its fractal dimension using the free HarFa imaging software
(www.fch.vutbr.cz/lectures/imagesci/).
When using threshold boundaries in an image, the IOD is deﬁned as the
weighted sum of the image histogram in which each term in the histogram is
multiplied by the gray value it represents (Walter and Berns, 1981) and is
expressed by the following equation:
𝐼𝑂𝐷(𝑇1, 𝑇2) = ∑𝑇2
𝐺𝑉=𝑇1 H(GV)𝑥 𝐺𝑉
where T1 and T2 represent the upper and lower thresholds deﬁning the ROI in
the histogram, GV the gray value of each pixel, and H(GV) the gray level
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histogram. Values of IOD were calculated directly from the integrated
morphometry subroutine of MetaMorph 6.1 software. Using the software’s optical
calipers, the measurements were reﬁned by setting speciﬁc boundary conditions
for area and IOD for acceptance of the signal from the individual MC and to
minimize or eliminate the contributions of any non-speciﬁc and background
staining. This concept of IOD representing the mass or total amount of stained
material in an ROI of an image is well-established and has been previously
applied to diverse topics including the translocation of nuclear factor κB in the
nucleus (Fuseler et al., 2006; Rogers and Fuseler, 2007), changes in actin
cytoskeleton in cardiac ﬁbroblasts (Fuseler et al., 2007) and adult stromal stem
cells (Fuseler and Valarmathi, 2012), and comparison of the architecture of
normal and tumor microvasculature (Fuseler et al., 2010).
The IOD measured for the MB-stained MC is a representation of the mass
and a measurement of the total amount of material in the delineated region. The
values of the IOD were normalized by being divided by the area (A) of the
thresholded ROI for the MC. The resulting term of IOD/A allows for comparisons
to be made between intact MC and MC that have experienced degranulation as
result of activation. Additionally, IOD/A provides the concept of mass density or
relative density (Smith et al., 1996) of the intact and degranulated MC. As a mass
measurement, the values of IOD/A provide further information on the structure
and distribution of pixels constituting the mass MC granules present within the
ROI.
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Fractal Dimension
MC granular cytoplasm is an irregular and complex object composed of
proteoglycan-containing granules at different levels of resolution, which are
functionally and physiologically similar (self-similar). Because of the complexity of
form, MC cytoplasm cannot be characterized or deﬁned by regular Euclidean
geometry or dimensions. Regular Euclidean dimension assigns an integer to
each point or set of points in Euclidean space and includes the familiar
geometrical descriptors or numbers: 0 to a point,1 to a straight line, 2 to a plane
surface, and 3 to a volume or three dimensional ﬁgures. These integer
descriptors are exponents of power functions that describe these objects (Brown
et al., 2002). Complex macro- or micro-anatomical structures cannot be analyzed
by regular Euclidean geometry, but can be described quantitatively by fractal
geometry (Mandelbrot, 1983; Smith et al., 1996). The fractal dimension of
complex or irregular structures can be described by non-integer numbers, with
values falling between two-integer topological dimensions. These non-integer
numbers are described as non-Euclidean and deﬁne the fractal dimension (D) of
an object. The concept of fractals currently provides a useful method to quantify
the inherent irregularity or complexity of phenomena (Zhang et al., 2006). In
general, a fractal is any rough and irregular object consisting of parts that are in
some way similar to the whole. Because of the self-similar conditions, MC
cytoplasm can be considered a fractal object and its fractal dimension (D),
expressed by a non-integer number lying between two Euclidean integer
topological dimensions (Grizzi et al., 2005). In the case of the two-dimensional
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images analyzed in this study, the values of D characterizing MC cytoplasm are
therefore fractional and lie between the Euclidean integers of 1 and 2.
The box-counting method has been the most widely used and general
model for applying fractal analysis to biological and non-biological systems and is
expressed by the formula:
Log𝑁(𝑒)
1
𝑒→0
Log(𝑒 )

D = lim

The box-counting method consists of a grid of boxes of side length size (e)
superimposed over the image of the structure and N(e) the smallest number of
boxes of side (e) required to cover the surface or outline of the object completely
(Dioguardi et al., 2006; Fuseler et al., 2007; Grizzi and Dioguardi, 1999). Since a
zero limit cannot be applied to a biological object, here the MC, the fractal
dimension is determined as the slope of a regression line when Log [N(e)] is
plotted against Log(1/e) i.e., D = Log [N(e)]/Log(1/e). From the images of
previously isolated and thresholded MC, the D values of the ROI were
determined using HarFA (full version 5.5.31) software (Nezadal et al., 2001). The
thresholded images of MC are assigned mesh sizes of boxes with (e) values
ranging from 2 to 215 pixels and 30 steps within this range were calculated to
generate the Log [N(e)] versus Log(1/e) plots, the slopes of which determine the
D values. In these 40× images, one pixel is equal to 0.229 μm. Fourteen images
were analyzed from each skin section of each animal (n = 4 mice).
Statistics
Data are expressed as means ± SEM. Signiﬁcance was determined by
analysis of variance and an appropriate post hoc test for multiple comparisons
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using Sigma-Plot software (Systat Software Inc., San Jose, CA, USA) and is
shown in ﬁgures.

2.3 RESULTS
Methylene Blue Staining of Normal Mouse Skin Sections for MC Detection
and Analysis
We used a classic staining technique to visualize MC in skin tissue
sections. Methylene blue (0.1 % MB) stains all nuclei of cells in blue. Because of
the metachromatic nature of the proteoglycans that compose the frame of MC
granules, the interaction of the dye molecules with proteoglycans results in an
absorption spectrum shift from blue to purple. Thus, metachromasia features
blue/purple cytoplasmic granules, unique to MC (Wolters et al., 2005). Even
though the metachromatic cytoplasmic staining is MC-speciﬁc, Figure 2.1a
shows that in situ MC detection can be challenging, at low magniﬁcation using a
10× objective of MB-stained skin section. Higher magniﬁcation using a 40×
objective (or High Power Field, HPF) of similar MC-stained skin tissue sections
allows for MC identiﬁcation, but illustrates the difﬁculty to decide, even with
blinded analysis and microscope aided human eyes, whether a particular MC
presents features of an intact or a degranulated cell (Fig. 2.1b). We developed a
method for rapid and unequivocal identiﬁcation of MC status, as follows: an intact
MC was deﬁned as a MC within and/or at the periphery of which no distinct
granule could be singled out in high power ﬁeld (HPF) (Fig. 2.1b, Intact MC).
Next, we deﬁned as degranulated, MC for which distinct individual granules could
be observed within and at the periphery of the cell in HPF (Fig. 2.1b,
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Degranulated MC). Figure 2.1c describes the analytic ﬂow chart employed to
quantitatively identify and distinguish between an intact and a degranulated MC.
To this end, two MC were randomly selected (Fig. 2.1b, Intact MC and
Degranulated MC), and then isolated as speciﬁc ROI to remove the background
(Fig. 2.1c, upper panels). Next, isolated MC images were color-thresholded (Fig.
2.1c, middle panels, orange coloring). The thresholding process was followed by
the actual determination of pixel intensity (Fig. 2.1c, lower panels, green coloring)
to measure the IOD parameter which sums the values of all the pixels in the
selection (cell). We noticed that the area occupied by and the morphology of
each MC could vary greatly. To take this variable into account, the area (A)
occupied by each cell was measured next and expressed in square μm. Because
intact MC granules are fully equipped with a variety of mediators whereas
degranulated MC have partly released the mediators harbored in their granules,
we reasoned that intact and degranulated MC must be characterized by
differential mass or IOD/A measurements, allowing for objective deﬁnition of
each of these cellular states.
Relative Mass Calculations Based on IOD/A Ratios Distinctly and
Quantitatively Characterize Intact and Degranulated MC
We further analyzed skin tissue sections collected from four different
animals, and randomly selected 90 intact and 90 degranulated MC, as described
above. Next, IOD and A parameters were calculated as described in Figure 2.1.
Quantitation of IOD/A ratios were carried out. As shown in Figure 2.2, intact MC
exhibit an average IOD/A ratio of 15.459 ± 2.18, which was signiﬁcantly
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decreased to 11.782 ± 2.109 in degranulated MC. Importantly, these results
quantitatively substantiate the notion that intact MC feature a higher mass
compared to degranulated MC. This procedure actually measures relative MC
mass and demonstrates this parameter to be signiﬁcantly attenuated upon
degranulation, in agreement with the biological relevance of the process.
Fractal Dimension Analysis Constitutes a Suitable Analytical Approach to
Further Deﬁne Morphometric Evaluations of Intact and Degranulated MC
We next considered that the size and volume parameters previously
calculated for each MC status could be complemented by quantiﬁcation of
comparative fractal dimension values. To this end, we sought to determine
whether fractal dimension, a measure of chaos and space ﬁlling capacity, could
be a useful discriminating factor between intact and degranulated MC, as there is
an increasing use of applied fractal geometry in the medical ﬁeld for pattern
recognition, texture analysis and segmentation. This type of analysis has been
performed to study cell nuclei and nuclear chromatin and has been demonstrated
as a useful prognostic tool in cancer (Ferro et al., 2011; Streba et al., 2015).
Therefore, we reasoned that the more ordered cytoplasm of an intact MC should
display contrasted fractal characteristics compared to a more heterogeneous,
less uniform cytoplasm of a degranulated MC. Figure 2.3a shows the procedure
to ﬁrst isolate cells to be analyzed from the tissue and second, proceed with
binarization of the image (i.e., generate a black and white image from a grayscale one). Binarized images are next used to calculate fractal dimension (D),
therefore quantifying the structural density of MC cytoplasm. D values of the two-
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dimensional images analyzed were between the Euclidean values of 1 (a straight
line) and 2 (an irregular, complex structure). Of note, fractal dimensions
constitute numerical descriptors which are exponents of power functions, i.e.,
nonlinear functions.
Fractal Analysis is a Reliable Method for Objective Quantiﬁcation of in situ
MC Degranulation
Analysis of normal skin samples collected from four different mice was
conducted using 14 images per animal and randomly chosen intact MC (n = 29 60 cells per animal) and degranulated MC (n = 14 - 29 cells per animal). The
fractal dimension of each cell was determined. The discriminatory performance of
D parameters is shown in Figure 2.4, indicating mean D values of 1.378 ± 0.621
and 1.484 ± 0.0489 for intact and degranulated MC, respectively. Surprisingly,
the D values characterizing each MC status were very consistent from animal to
animal, suggesting the potential relevance of fractal signatures to objectively
evaluate MC activation status. Moreover, mean D values of degranulated MC
were signiﬁcantly augmented compared to mean D values of intact MC. We
established that computer-assisted morphometric MC analysis performed on
microscopy images of tissue samples may overcome the time-consuming and
subjective examination that necessitates expertise and extensive observer
training.

2.4 DISCUSSION
Key components of innate immunity, MC are present in tissues apposed to
the vasculature in homeostatic conditions (Reber et al., 2012). They harbor
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numerous intracytoplasmic granules, large dense core vesicles composed of a
proteoglycan matrix where many mediators are pre-stored, including vasodilating
histamine, cytokines and chemokines (Wernersson and Pejler, 2014). Beside
their canonical activation through the cross-linking by antigen (Ag) of
immunoglobulin E (IgE) bound to their high-afﬁnity receptors, MC express a
plethora of receptors, including Toll-like receptors, and receptors for complement,
cytokines, chemokines, neurotransmitters and sphingosine-1-phosphate (S1P),
the ligation of which could also trigger further MC activation (Oskeritzian, 2015;
Oskeritzian et al., 2008; Oskeritzian et al., 2015; Oskeritzian et al., 2010;
Theoharides et al., 2012). Moreover, microenvironmental physical/mechanical,
pH, osmolarity and temperature alterations and UV radiation can also activate
MC. Degranulation or the exocytosis of granules is the most prominent process
indicative of MC activation. MC stimulation is traditionally monitored through the
detection of granule-associated mediators measured in the circulation upon
release. However, a systemic appreciation of MC activation, though relevant and
sometimes life-threatening such as upon anaphylactic shock, does not inform on
the status of local MC in tissues. As outlined above, the distinctive ability of MC
to produce and pre-store large concentrations of many mediators positions these
cells as ﬁrst-line responders thus shaping the initial local response to trauma. We
have previously reported that IgE/Ag- and S1P-mediated activation of MC
delivers locally several cell-recruiting chemokines, thus endowing MC with early
guidance of inﬂammatory events (Oskeritzian et al., 2008; Oskeritzian et al.,
2015; Oskeritzian et al., 2010). This is particularly important in skin disorder
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pathogenesis as the positioning of large numbers of MC is substantiated in the
dermis and the hypodermis, subcutaneous fatty tissue layer of rodent and human
skin (Hart et al., 1999; Hart et al., 1998). Strong evidence suggests an
association between MC-derived functions and the mediator repertoire they
differentially release owing to the nature of stimulation (Galli et al., 2008;
Kalesnikoff and Galli, 2008).
Intragranular proteoglycan interaction with dye molecules of MB results in
a metachromatic staining of granules speciﬁc to MC, the only tissue-resident
cells that display these distinct blue/purple-colored granules in their cytoplasm.
Of note, although circulating basophils share some phenotypic and functional
features, they differ from MC in many aspects of natural history, granule contents
and functions (Voehringer, 2013). Relevant to our study, basophils are not found
in normal tissues (Arock et al., 2002), but could be recruited into inﬂamed sites
(Voehringer, 2013). Importantly, the main histochemical difference that allows
distinguishing MC from basophils resides in differential metachromatic staining.
Namely, MC granules comprise both heparin and chondroitin sulfate (CS)
proteoglycans, whereas basophil granules present CS but do not contain heparin
and are fewer in number compared to MC granules, thus resulting into weak
staining with basic dyes (Voehringer, 2013). Other distinct features of MC are
their round nuclear morphology and a cell size ranging from 5 to 10 μm,
conversely to basophils that display lobulated, indented or segmented nuclei and
an overall smaller size of 5 – 7 μm compared to MC (Voehringer, 2013).
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While easy to identify in MB-stained tissue sections, deﬁning MC
activation status remains challenging even for a trained observer and is a source
of considerable inter-observer variability. Since MC are tissue-resident and could
initiate or suppress immune responses, they constitute an emerging target
candidate for ﬁne-tuning the local microenvironmental responsiveness, therefore
pathogenesis and carcinogenesis (Oskeritzian, 2015). There is increasing need
for a better understanding pertaining to the relationship of MC in inﬂammation
and cancer as it seems diversiﬁed and therefore ill-understood (Giannou et al.,
2015; Oldford and Marshall, 2015; Oskeritzian, 2015; Ribatti, 2013). Indeed,
many studies acknowledge the presence of increased MC numbers in numerous
pathological conditions, yet reporting the more relevant and tractable local
percentage or number of degranulated MC is not recognized as strong univariate
data that often needs to be validated by quantitating MC-derived mediators in
biological ﬂuids.
In this study, we developed a computerized method for morphometric
analysis of MC based on objective parameter measurements in routinely MBstained normal skin tissue sections. Of relevance to MC granularity and
morphology, these criteria include mass and relative density measurements
based on IOD and area (A) ratios and fractality, which implies scale-independent
self-similarity. We discovered that, independent of the subject, intact skin MC are
consistently characterized by a mass (IOD over A ratio) signiﬁcantly higher than
degranulated MC. Of note, the IOD/A ratios of intact or degranulated MC were
surprisingly consistent from cell to cell in each group and from animal to animal,
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further highlighting the reproducibility and validity of our newly developed
analytical method. Interestingly, the use of IOD and A parameters have
previously been applied to dermal MC as a tool to quantify histamine content, but
not to provide a measurement of MC activation as demonstrated herein (Hart et
al., 1999; Hart et al., 1998).
The examination of fractal characteristics has been convincingly relevant
to analyze chromatin structure and nuclear texture, providing important
diagnostic and prognostic information for patients with acute leukemia and
multiple myeloma (Ferro et al., 2011). Fractal analysis has been widely applied in
the past to quantify cytoskeleton morphology (Fuseler et al., 2007; Fuseler and
Valarmathi, 2012; Qian et al., 2012), cellular shape (Jelinek et al., 2011; Sedivy
et al., 2002; Wick et al., 2003), vasculature structure (Anderson et al., 2005; Di
Ieva et al., 2007; Fuseler et al., 2010; Grizzi et al., 2005), vascular sprouting
(Doubal et al., 2010; Moledina et al., 2011) and tumor microvasculature (Di Ieva,
2012; Fuseler et al., 2010). More recently, it was successfully applied to quantify
collagen ﬁbrotic lesions of the liver (Dioguardi et al., 2008; Dioguardi et al., 2006)
and the heart (Zouein et al., 2014). Microscopy evaluation of the MC
degranulation process requires high magniﬁcation analysis and could be difﬁcult
given staining variations occurring in routine slide preparations. We took
advantage of the fact that fractals are scale independent and their determination
based on thresholded images less dependent on staining intensity. Methylene
blue is one of the most common metachromatic staining methods and wellestablished histological approach to detect MC through the unique staining of
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their granules (Wolters et al., 2005). As such, it could be used to distinguish
intact from degranulated MC. However, observer-based analysis often yields
inconsistent data, varying with the individual grading of MC status and provides
semi-quantitative estimates of MC degranulation rather than reliable quantitation
partly because of the irregular shapes tissue MC display in situ. Thus, MC
cytoplasm, 80% of which is occupied by granules, is highly polymorphic and
irregular in shape. To overcome these conditions, we considered the
granule/cytoplasm mass as a fractal object, a concept developed by Mandelbrot
(1982) that provides a theoretical framework for many biological processes and
objects. Thus, the fractal property relates to a measurement variable and a
fractal object or process can reveal fractal characteristics of many different
variables or features. We measured the fractal dimension (D) of intact and
degranulated MC, as a measure of the comparative space ﬁlling capacity and
complexity or structural density of MC in these two different biological stages,
using digitized two-dimensional images. We discovered that D associated with
intact MC is consistently and signiﬁcantly lower than D of degranulated MC in a
reproducible manner. These important results suggest that the measure of D can
quantitatively distinguish intact from degranulated MC, regardless of cellular
morphology which could greatly vary. Together with the relative density
measurements provided by the IOD/A ratios, which determines the structure
and/or distribution of the granular material within a MC (our region of interest), we
demonstrate that the measure of D generates a quantitative description of
mammalian MC status. We are currently exploring the feasibility of acquiring
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these data in a semi-automated manner for potential diagnosis/prognosis
applications to compare the analysis of healthy and diseased tissue sections in
MC related disorders. We attributed the detection of some degranulated MC in
normal skin to the procedure for sample preparation that requires shaving of the
mouse back skin. This mandatory step constitutes a mild but perhaps signiﬁcant
mechanical stimulus leading to a low but detectable incidence of dermal MC
activation.
Despite the differences between mouse and human skin, mouse models
of human disease remain prevalent, and in many cases genes of interest are
deregulated and/or mutated in both species (Gerber et al., 2014). The vast
abundance of disease models, knockout and transgenic strains ensure that
mouse models will remain a highly relevant mainstay to the study of skin biology
(Gerber et al., 2014). Therefore, our morphometric method of MC analysis was
ﬁrst developed using mouse skin samples. Applying this morphometric method to
human samples would assist clinicians and hospitals with providing a rapid
determination of MC activation status, including in suspected cases of MC
activation syndrome, mastocytosis, and anaphylactoid versus genuine
anaphylactic reactions (Akin et al., 2010; Hamilton et al., 2011; Valent et al.,
2011). A previous report applied fractal dimension and lacunarity or
measurement of roughness to characterize MC degranulation in rainbow trout
(Manera et al., 2014). Although informative, this study did not use mammalian
MC. Moreover, MC degranulation was triggered in a receptor-independent
manner using compound 48/80, a synthetic polyamine basic secretagogue
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composed of mixed polymers of phenylethylamine cross-linked by formaldehyde
of undetermined ratio thus precluding calculation of molar concentrations
(Manera et al., 2014). Our study establishes that mouse skin MC status can be
quantiﬁed at homeostasis using fractal geometry, image analysis and readily
available standard bright ﬁeld microscopy on tissue sections routinely stained
with MB, providing in situ quantiﬁcation of MC activation. We are currently
applying similar approaches to complementary MC immunohistochemistry
staining techniques designed to phenotype MC subsets. Introduction of the
fractal theory in biology and medicine has already led to a better understanding
of many physiological processes, including allosteric enzyme kinetics,
intracellular bioenergetic dynamics, metabolic rate, drug clearance modeling,
angiogenesis, cardiovascular physiology and tumor growth (Aon et al., 2008;
Ferro et al., 2011; McNally and Mazza, 2010; Thamrin et al., 2010). Here we
demonstrate in situ quantiﬁcation of MC status in mammalian tissue samples,
combining relative density and fractal dimension measurements of MC
cytoplasmic density and order. Furthermore, we propose that this morphometric
analysis is applicable to patient samples and provide quantitative data pertaining
to local MC activation in tissue sections in clinical settings.
We demonstrate the ability to quantify in situ MC activation using
computer-assisted image analysis and biological specimens, based on fractality
and mass measurements. Reproducible, consistent and quantitative data were
collected from multiple skin samples, establishing that signiﬁcantly different
morphometric parameters are featured in intact and degranulated MC. This
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method may be further developed as a rapid diagnostic tool for the formulation of
MC involvement in research and clinical settings.
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Figure 2.1 Methylene-blue stained mouse skin for MC detection and
analysis. a: Methylene blue (MB)-stained mouse skin tissue section. Scale bar is
200 μm. b: MB-stained mouse skin tissue section with a selection of two
randomly selected and isolated mast cells (MC) (Scale bar = 50 μm); an intact
MC and a degranulated MC. c: Isolated MC images are color-thresholded
(orange), followed by measurement overlay (green) to allow for relative density
and mass measurement IOD/A determinations.
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Figure 2.2 Comparison of mass between intact and degranulated MC.
Comparative relative density and mass measurements as integrated optical
density (IOD) over Area (A) ratios for intact and degranulated MC in skin samples
of four different normal mice (**p<0.001).
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Figure 2.3 Fractal dimension to identify intact and degranulated MC. Fractal
dimension (D) is a morphological descriptor of chaos and space ﬁlling capacity of
MC cytoplasm. a: For measurement of D, the digitized image in Figure 2.1b was
thresholded to generate a black and white 8-bit gray scale image from the color
image. b: Threshold images were generated using the free HarFa software,
which includes several ﬁltration algorithms to eliminate thermal noise associated
with the digital camera and illumination variations (gray scale) across the image.
Scale bar is 50 μm.
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Figure 2.4 Fractal dimension of degranulated MC is higher than intact MC.
Comparative fractal dimension (D) analysis for intact and degranulated MC in
skin samples of four different normal mice (14 images per animal were
analyzed). Degranulation of MC increased the D values signiﬁcantly and
consistently, compared to D values of intact MC (**p<0.001).
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CHAPTER 3: MAST CELLS AND SPHINGOSINE-1-PHOSPHATE UNDERLIE
EARLY PATHOGENIC REMODELING IN PRE-LESIONAL ECZEMA2
3.1 INTRODUCTION
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease
that affects 15-30% children and 2-10% adults world-wide (Auriemma et al.,
2013; Darlenski et al., 2014; Eyerich and Novak, 2013; Graham and Nadeau,
2014; Liu et al., 2011; Nakamura et al., 2013; Patrizi et al., 2011; Szegedi et al.,
2015). This complex multifactorial disorder often features hypersensitivity to
environmental agents and immune dysfunction (Auriemma et al., 2013; Elias,
2014; Eyerich and Novak, 2013; Kim et al., 2014; Liu et al., 2011; Mu et al.,
2014; Patrizi et al., 2011). Yet, the sequential events leading to eczematous
lesions and AD etiology are not completely understood.
Interestingly, 70-80% of AD patients have increased levels of total serum
IgE antibodies (Ando et al., 2013; Auriemma et al., 2013; Darlenski et al., 2014;
Kendall and Nicolaou, 2013; Liu et al., 2011; Patrizi et al., 2011). Perivascular
accumulation of lymphocytes and mast cells (MC) are observed in chronic
lesions (Ando et al., 2013). However, few studies have investigated the initial
phase leading to lesions, including events prior to IgE production (Gittler et al.,
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2012; He et al., 2007; Kim et al., 2014; Spergel et al., 1998; Wang et al., 2007;
Zhu et al., 2015). Equipped with surface receptors for IgE (FcεRI) and other
ligands and tissue-resident at homeostasis, MC play an important role as
initiators of inflammation and first-line responders to inflammatory signals (Griffith
et al., 2014; Oskeritzian, 2015; Oskeritzian et al., 2015; Oskeritzian et al., 2010).
Moreover, MC present the unique ability to produce and store many vasoactive
and cytoactive mediators in their cytoplasmic granules prior to trauma and also
neo-synthesize bioactive products upon activation (Galli and Tsai, 2012;
Kalesnikoff and Galli, 2008; Mu et al., 2014; Nakamura et al., 2013; Oskeritzian,
2015; Oskeritzian et al., 2015; Oskeritzian et al., 2010; Zhu et al., 2015). We
recently established that MC and a potent sphingolipid metabolite, sphingosine1-phosphate (S1P) are at the nexus of inflammatory infiltration in early lung
allergic responses (Oskeritzian et al., 2015). We previously reported that MCderived S1P, produced by sphingosine kinase (SphK), can be exported out upon
activation, amplify MC cytokine/chemokine production by autocrine binding to
S1P receptors and regulate cell trafficking (Mitra et al., 2006; Oskeritzian, 2015;
Oskeritzian et al., 2008; Oskeritzian et al., 2015). S1P can also activate MC
independently of the canonical IgE/FcεRI pathway (Chumanevich et al., 2016;
Kendall and Nicolaou, 2013; Oskeritzian et al., 2015; Oskeritzian et al., 2010).
In the current study, we investigated AD pathogenesis using a variation of
a well-established human AD-like mouse model and collected skin samples for
analysis after a single epicutaneous (EC) exposure to OVA Ag (Spergel et al.,
1998). We discovered a new pathogenic pathway leading to AD that links cell
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infiltration of the hypodermis to local MC activation and S1P elevation. Next, we
examined skin remodeling in mice deficient for SphK1 or MC and after LPS-free
OVA exposure and established an essential role for MC, S1P and LPS at the
onset of AD.

3.2 MATERIALS AND METHODS
Atopic dermatitis model
AD was induced in 8 to 12 weeks of age-matched female C57Bl/6J (WT),
SphK1 KO (SphK1tm1Rlp), and MC-deficient KitW-sh/W-sh (B6.Cg-KitWsh/HNihrJaeBsmGlliJ)

mice as previously described (Spergel et al., 1998),

purchased from Charles River NCI (Frederick, MD) and The Jackson Laboratory
(Bar Harbor, ME). After simple randomization using shuffled pieces of paper that
indicated saline, OVA or LPS-free OVA, mice were assigned to either
experimental group. Then, 100 µl of OVA solution (100 µg OVA (Sigma-Aldrich,
St Louis, MO) or LPS-free OVA (100 µg EndoGrade® OVA (Hyglos GmbH,
Munich, Germany) in 0.9% saline) or 0.9% saline only (saline control) were
pipetted on a 1 cm x 1 cm square gauze pad (patch) placed on the shaved and
tape-striped upper-back skin area. Next, this area was occluded with a Tegaderm
Transparent Dressing (3M HealthCare, St Paul, MN) using bandages. Patch was
removed after seven days and skin samples collected from euthanized mice. For
patch 3-IgE determinations, the full AD protocol was conducted exactly as
previously described (Spergel et al., 1998). Briefly, each patch was secured for
one week followed by two weeks of rest before next exposure week. Patch 1 and
patch 3 sera were prepared from blood collected by cardiac puncture
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immediately after euthanasia and stored at -80oC until use. Animal experiments
and all experimental protocols were approved by the University of South Carolina
Institutional Animal Care and Use Committee. Animal experiments and all
methods were performed in accordance with the relevant guidelines and
regulations.
Histology and Microscopy
Skin tissues collected from euthanized mice were fixed in 4% fresh
paraformaldehyde. Fixed tissues were embedded in paraffin, sectioned (4 µm
thickness) and mounted on microscope slides. One group of slides was stained
with Hematoxylin and Eosin (H&E) for skin morphometric analysis. To visualize
MC, a second group of slides was placed in 0.1% methylene blue (MB) for five
seconds, rinsed with water, dehydrated in 100% ethanol and mounted under
coverslips with cytoseal 60 (Wolters et al., 2005). Sections were imaged with a
Nikon E-600 microscope (Nikon Inc., Melville, NY) equipped with a
Micropublisher digital camera model 5.0 and images collected as TIFF files with
the Micropublisher software at low (10x, numerical aperture 0.30) and high (40x,
numerical aperture 0.75) magnification for analysis. Images were analyzed as
24-bit color images or 8-bit monochrome images, as required, using the
QImaging software version 2.0.13 (QImaging Corp., Surrey, BC, Canada).
Morphometric and fractal parameters of nuclei (infiltration, 25-30 ROIs/image, a
minimum of twelve 40x-images/skin section; 4 skin sections/2 mice/treatment
group) and MC (percent degranulation, fifty 40x- total images/310-485 total MC;
4 skin sections/2 mice/treatment group) were measured using the MetaMorph®
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6.1 Microscopy Automation and Image Analysis software (Molecular Devices,
Sunnyvale, CA) and the free HarFa imaging software
(www.fch.vutbr.cz/lectures/imagesci/), as previously described (Wedman et al.,
2015). For these and all quantifications described below, the investigators who
were making measurements were blind to slide group allocations (single blind
studies).
Morphometric measurement of skin remodeling
The thickness of each skin layer (epidermis, dermis and hypodermis) was
measured in saline- and OVA-treated specimens using an ocular micrometer
(Klarmann Rulings, Inc., Litchfield, NH). From each slide, uniform regions of the
epidermis, dermis and hypodermis were selected and the average thickness was
measured (n= 3-5 measurements/3-5 animals/treatment group/skin layer (i.e,
epidermis, dermis, hypodermis).
Computer-assisted quantification of hypodermal cellular infiltration
A recent computer-assisted imaging method developed by our laboratory
(Wedman et al., 2015) was adapted to quantify cellular infiltration. A minimum of
twelve high-magnification H&E images per animal was used to determine cellular
infiltration in the hypodermis. To this end, nuclei were isolated by means of color
thresholding using the set color threshold subroutine of the MetaMorph software
(orange color overlay) and quantified by applying a fixed circular region of
interest (ROI, diameter=75µm) of constant area that was moved sequentially to
adjacent regions to survey the entire hypodermis of each section (n=25-30
ROIs/section, 2 sections/slide, 2 slides/animal, 2 animals/treatment). The
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morphometric parameters of the nuclei (area, perimeter and integrated optical
density determined using the Integrated Morphometry Analysis subroutine of
MetaMorph) were used to refine nuclei measurements and eliminate any
background noise.
Validation of cellular infiltration quantification by independent fractal
dimension analysis
As described above, fixed circular ROIs were isolated and collected as
TIFF file images throughout the hypodermis of H&E images in each section. The
hue, saturation and intensity values were adjusted to isolate the nuclei in orange
as a thresholded region. The images of the individual isolated and selected
nuclei (green) were converted to a 8-bit gray scale image for further fractal
dimension measurements using the free HarFa imaging software
(www.fch.vutbr.cz/lectures/imagesci/), which converts the gray-scaled image into
a binary one, as we previously described (Wedman et al., 2015). Briefly, an area
featuring cellular infiltration is an irregular and complex object composed of
nuclei, which are fundamentally similar (self-similar). Because of its complexity,
infiltration cannot be described by regular Euclidean geometry that uses integer
descriptors (Brown et al., 2002; Wedman et al., 2015). Instead, it can be
described quantitatively by fractal geometry using non-integer numbers, with
values falling between two-integer topological dimensions (Mandelbrot, 1983;
Smith et al., 1996). These non-integer numbers define the fractal dimension (D)
of an “object”, here, the distribution of nuclei within a hypodermal ROI. As
discussed previously (Wedman et al., 2015), the concept of fractals provides a
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useful method to quantify the inherent irregularity or complexity of phenomena. In
the case of the two-dimensional images analyzed in the current study, the values
of D characterizing cellular infiltration are therefore fractional and lie between the
Euclidean integers of 1 and 2.
In situ determination of mast cell degranulation
The MC granular cytoplasm is an irregular and complex object composed
of proteoglycan-containing granules at different levels of resolution that are
functionally and physiologically similar (self-similar). Thus, it can be considered
as a fractal object and analyzed accordingly. Using this approach, we previously
demonstrated (Wedman et al., 2015) that MC cytoplasm cannot be characterized
by regular Euclidean geometry because of its complexity of form but can be
described quantitatively as degranulated or intact by fractal geometry and
dimension (Mandelbrot, 1983; Smith et al., 1996), with values ranging between 1
and 2. We previously established that the fractal dimension (D) value uniquely
characterizing intact MCs is 1.378 ± 0.062 and the D value describing
degranulated MCs is 1.484 ± 0.048 (Wedman et al., 2015). These values were
used as a baseline for non-subjective quantification of intact and degranulated
MC numbers in the skin samples of saline- and OVA-treated animals (n=2
animals/treatment).
Quantitative Real-Time qPCR
Skin samples were collected, snap-frozen and stored at -80oC until RNA
extraction. Total RNA from saline-treated skin samples (n=4-8 animals) and
OVA-treated skin samples (n=6-10 animals) was isolated and purified with the
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miRNeasy kit (Qiagen, Valencia, CA), following the manufacturer’s procedure.
The iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) was used according to
the manufacturer’s specifications to reverse transcribe cDNA. QPCR was
performed on a CFX Connect (Bio-Rad) with SensiFAST™ SYBR No-ROX Kit
(Bioline, Taunton, MA). Primer sets used in real-time qPCR amplification are
displayed in Table 3.1. The real-time qPCR conditions were as follows: initial
step at 95°C for 5 min and cycles (n=40) consisted of 10 s at 95°C, followed by 1
min annealing at 55°C and extension at 72oC. All reactions were performed in
duplicate. Data were analyzed with CFX Manager™ Software and are
normalized expression to saline-treated samples and directly proportional to the
amount mRNA of the target gene relative to the amount of mRNA of the
reference gene, GAPDH mRNA levels. Primers were purchased from Thermo
Fisher Scientific, Inc. (Waltham, MA).
Multiplex Assays
The following chemokines were measured in mouse serum or in mouse
skin protein extracts (n=10-12 mice/treatment/sample type) with a Bio-Plex Array
Reader (LUMINEX 100; Bio-Rad Laboratories, Hercules, CA) with murine
Milliplex panels (EMD Millipore, Billerica, MA): CCL2/monocyte chemoattractant
protein 1, CCL3/macrophage inflammatory protein 1α and CCL5/RANTES.
Mouse skin protein extracts were obtained from skin specimens harvested after
one week of exposure to OVA or saline, weighed, and frozen in liquid nitrogen.
Each sample was homogenized with a mortar and pestle and digested for 2 h at
4°C in Reporter lysis buffer (Promega, Madison, WI) supplemented with
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complete mini-protease inhibitor tablets (Roche Diagnostics, Indianapolis, IN).
Supernatants were stored at −80°C and quantified for chemokine content, as
indicated above.
Total Serum IgE ELISA
Mouse total serum IgE was measured by ELISA, according to
manufacturer’s instruction (R&D Systems, Minneapolis, MN). N=6
animals/experimental groups for one exposure and n=9 animals/experimental
groups for three exposures.
Lipidomics
Lipids were extracted from snap-frozen skin tissues and S1P was
measured by using liquid chromatography-electrospray ionization-tandem mass
spectrometry (4000 QTRAP; AB Sciex, Foster City, CA), as previously described
(Hait et al., 2009). Quantification of S1P was normalized to weight of skin
sample. N=3-4 samples per experimental group.
Statistics
Data are expressed as means + SEM (unless otherwise stated) and were
analyzed by using the unpaired 2-tailed Student t test, with Welch’s correction for
samples of unequal variance (Prism 6; GraphPad Software, La Jolla, CA).
Significance for all statistical tests is shown in figures. Experiments were
repeated at least 3 times in triplicates with consistent results. In vivo experiments
were repeated 3 times, and each experimental group consisted of 5 to 6 mice.

42

3.3 RESULTS AND DISCUSSION
OVA triggers rapid skin remodeling and cellular infiltration
We previously reported that systemic Ag stimulation leads to early lung
remodeling in sensitized mice (Oskeritzian et al., 2015). These studies prompted
us to revisit the development of another inflammatory disease of atopic nature,
AD, for which the initiating mechanisms remain ill-understood (Leung and
Guttman-Yassky, 2014; Malajian and Guttman-Yassky, 2015). We found that
epidermal and dermal thickening that is observed in the 49-day AD mouse model
(Spergel et al., 1998; Wang et al., 2007), was already significant albeit modest
after one OVA application, compared to one saline treatment (Figures 3.1a-c).
We observed a marked cellular infiltration in the hypodermis, compared to
saline controls (Figures 3.1a-c). We adapted our recently established image
quantification method (Wedman et al., 2015), to measure cellular infiltration
(Figure 3.1d) in a defined region of interest (ROI) (circle in Figure 3.1e)
sequentially moved across the entire hypodermis. Figure 3.1g shows whole
hypodermis survey of infiltration in a representative saline-treated skin sample
compared to an OVA-treated one, in which blood vessel (Bv)-containing ROI are
depicted in red. Saline treatment triggered some infiltration, increased around Bv.
The OVA application drastically increased hypodermal cell numbers, also around
Bv (Figure 3.1g). The statistical validation of these results was demonstrated by
analyzing multiple samples (Figures 3.1f, h).
Having previously established the relevance of fractal dimension to define
morphometric descriptors (Wedman et al., 2015), we reasoned fractals or
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measures of space filling capacity could also represent an accurate method to
quantify cellular infiltration. Figures 3.1i-j describe the procedure established to
isolate nuclei/cells. Next, binary images (Figure 3.1k) were generated to calculate
fractal dimensions (D) of ROI by quantifying the structural density of the “objects”
(nuclei) or cellular infiltration. Figure 3.1l independently confirmed the increased
cellular infiltration substantiated in Figures 3.1f-h after OVA treatment as
measured by D values of multiple skin samples. The discriminatory performance
of D was further validated in Figure 3.1m, also showing increased infiltration
around the BV.
Importantly, the present study analyzed prelesional skin specimens,
therefore identifying novel histo-pathological mechanisms of pre-symptomatic
AD. We described a new morphometric method to quantify rather than score
cellular infiltration that uncovered a prevalent although previously unnoticed
hypodermal infiltration after a single OVA treatment, suggesting an important
function for the hypodermis at the onset of AD. We propose this initial infiltration,
also reported in acutely inflamed airways (Oskeritzian et al., 2015), could
constitute a novel target to prevent disease manifestation.
OVA stimulates local and systemic chemokines
We next investigated chemokine expression in treated skin samples
collected from both treatment groups. Skin mRNA expression for CCL2, CCL3
and CCL5, three members of the chemokine network we previously identified as
major contributors to airway inflammation (Oskeritzian et al., 2015) were all
significantly increased after OVA exposure (Figure 3.2a). Interestingly, skin CCL2
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(Figure 3.2b) and CCL3 (Figure 3.2c) (but not CCL5 (data not shown)) protein
levels were also increased upon OVA application, compared to saline controls.
As expected, circulating chemokine levels did not exactly corroborate local
levels. Serum CCL2 levels remained unchanged after EC OVA (Figure 3.2d),
whereas serum CCL3 and CCL5 were enhanced (Figures 3.2e-f). Recently, a
meta-analysis also described increased chemokine mRNA expression in patients
with AD (Ewald et al., 2015). CCL2 and CCL3 genes were also identified in
patients with moderate-to-severe AD by next-generation RNA-sequencing
(Suárez-Fariñas et al., 2015). Combined with our finding, these studies also
suggest an important role of infiltration in the establishment of AD.
OVA exposure elicits significant IgE-independent skin MC degranulation and
S1P elevation
Further interrogating skin gene expression, we found that mRNA coding
for the α chain of FcεRI (FcεRIα) was significantly up-regulated in OVA-treated
mouse skin samples (Figure 3.3a). Importantly, the α chain is responsible for IgE
binding to its receptor and initiates MC activation during allergic responses
(Metzger et al., 1986). Although expressed by Langerhans (Haas et al., 1993)
and other cells (Ying et al., 1998), we reasoned that skin-resident MC could also
contribute to the enhanced FcεRIα mRNA detection in these samples.
Microscopy examination of methylene blue (MB)-stained skin sections revealed
that metachromatic MC were distributed throughout the skin layers, irrelevant of
treatment (Figures 3.3b-c). Using our previously reported MC morphometrics,
skin sections were analyzed for MC activation (Wedman et al., 2015). Figures
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3.3b-c show representative examples of resting (green-framed insert, circle and
arrow) MC and degranulated (red-framed insert, circle and arrow) MC. MC
activation was morphometrically measured in whole hypodermis of samples to
calculate the percentage of MC degranulation. Figure 3.3d demonstrated that
skin MC were significantly more degranulated after OVA than after saline
application. While it has been shown that AD features increased perivascular MC
(Damsgaard et al., 1997; Kawakami et al., 2009), MC numbers were unaltered in
either treatment in the current study (data not shown). Of note, a recent report
delineated a protective role for MC during the development of spontaneous ADlike disease in a transgenic mouse model but did not measure local skin MC
activation (Sehra et al., 2016). Our finding of increased in situ MC degranulation
at this early subclinical stage of AD was novel and intriguing. As expected, seven
days of OVA exposure did not suffice to enhance circulating IgE levels (Figure
3.3e), compared to its abundant detection after 3 OVA treatments (Figure 3.3e)
as originally described (Spergel et al., 1998).
MC can be activated by S1P, an influential sphingolipid metabolite
resulting from the phosphorylation of its precursor sphingosine by SphK
(Chumanevich et al., 2016; Oskeritzian et al., 2008; Oskeritzian et al., 2015;
Oskeritzian et al., 2010; Rivera et al., 2008). Quantitative lipid analysis of skin
samples, using lipidomics mass spectrometry (Hait et al., 2009), revealed that
S1P was significantly increased in mouse skin after one exposure to OVA,
compared to saline controls (Figure 3.3f). In agreement, SphK1 skin mRNA
expression was also augmented after a single OVA application (Figure 3.3g). We
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have shown that S1P-mediated MC activation led to the release of cell recruiting
chemokines (Oskeritzian et al., 2008; Oskeritzian et al., 2015; Oskeritzian et al.,
2010; Price et al., 2013) and MC may serve as a local source of S1P (Mitra et al.,
2006; Oskeritzian et al., 2008), including when activated by mechanical stress
such as tape-stripping, and induce leukocyte rolling in inflamed mouse venules
and human endothelial cells (Nussbaum et al., 2015). MC are established
chemokine producers in the chronic phase of AD (Griffith et al., 2014; Zhu et al.,
2015) and mediate leukocyte recruitment (Gonzalo et al., 2007; McAlpine et al.,
2012; Ohsawa and Hirasawa, 2012; Oskeritzian, 2015; Wu et al., 2013), although
dispensable in a genetic mouse model (Sulcova et al., 2015). In the present
study, it is noteworthy that local chemokine detection and MC activation occurred
prior to IgE production. While augmented in most AD patients (Ando et al., 2013;
Liu et al., 2011; Patrizi et al., 2011), our data suggest that IgE may contribute to
AD progression rather than initiation. Importantly, our results strongly support MC
and S1P as early contributors to the development of pre-AD-related skin
alterations.
SphK1 or MC deficiency protects against OVA-driven skin remodeling and
infiltration
To determine the relevance of S1P in the observed pre-symptomatic skin
changes, we repeated the adapted AD protocol in SphK1 KO mice (Allende et
al., 2004), of genetic background similar to the WT mice we used so far (Figures
3.1-3.3). SphK1 deficiency mitigated OVA-initiated skin remodeling (Figures 3.4a
vs. 3.1c). The SphK1-null hypodermis surveying revealed a slight but significant
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increase in nuclei (i.e., cell) numbers after OVA, compared to saline-treated skins
(Figure 3.4b), that was less pronounced than in SphK1-sufficient mice (Figures
3.4b vs. 3.1f) and absent around the Bv (Figures 3.4c vs. 3.1h). Consistent with
these results, the pattern of OVA-restricted chemokine gene induction in
corresponding WT skin samples (Figure 3.2a) was not observed in SphK1 KO
mouse skins (Figure 3.4d). Importantly, genetic ablation of SphK1 prevented
OVA-initiated local up-regulation of FcεRIα mRNA expression (Figures 3.4d vs.
3.3a) and skin MC degranulation (Figures 3.4e vs. 3.3d). These results strongly
suggest that S1P is a driving mediator of IgE-independent skin remodeling and
infiltration through local skin MC degranulation in AD pathogenesis.
To investigate MC’s contribution to skin remodeling, we conducted OVA or
saline EC exposure of MC-deficient KitW-sh/W-sh (Grimbaldeston et al., 2005) mice.
Although some epidermal thickening was observed, KitW-sh/W-sh dermal layers
were unaltered (Figure 3.4f), compared to MC-sufficient mice of similar genetic
background (Figure 3.1c). Furthermore, MC deficiency prevented cellular
infiltration of the hypodermis (Figures 3.4g-h), suggesting a critical role of MC in
skin inflammatory responses. This was further confirmed by the absence of OVAinduced up-regulation of chemokine, FcεRIα and SphK1 mRNA levels (Figure
3.4i). It is noteworthy that skin-associated S1P levels were significantly lower and
not increased upon OVA application in KitW-sh/W-sh mice (Figure 3.4j), compared to
the corresponding WT mice (Figure 3.3f), supporting skin MC as a relevant local
source of S1P.
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Thus, it is tempting to speculate that MC may act as causative agents of
inflammatory response of the skin, similar to our recent report pertaining to lung
allergic responses (Oskeritzian et al., 2015). Moreover, local elevations of S1P in
inflamed skins may contribute to early MC activation at the inception of AD,
perhaps prompting MC themselves to further produce S1P. Keratinocytes
(Oizumi et al., 2014) and Langerhans cells (Japtok et al., 2012) could also
contribute to local S1P release. Nonetheless, our results suggest an important
function for MC activation at the onset of AD, linking S1P and chemokines to
early skin remodeling, thus setting the stage for the progression to AD.
Decreased S1P in human AD has been evoked but not measured (Japtok et al.,
2014). In agreement with previous studies (Dillahunt et al., 2013; Oskeritzian et
al., 2008), our data evoke a strong interdependency not only between 1) the
presence of SphK1 and skin MC activation but also 2) skin S1P level alterations
and the presence of MC. Thus, our study evokes local S1P and MC as potential
triggering components of skin remodeling in early AD.
Cellular infiltration, MC activation and local S1P elevation are abrogated in
mice treated with lipopolysaccharide (LPS)-free OVA
Yoon et al. recently established that endogenous TLR4 ligands are
essential to epidermal thickening observed in EC-sensitized skin after tapestriping (Yoon et al., 2016). Furthermore, commercial-grade OVA, used in this
and most studies, contains high LPS levels, a TLR4 ligand (Watanabe et al.,
2003). To investigate the LPS contribution to the early skin inflammation upon
EC OVA exposure, experiments were repeated using LPS-free OVA. EC LPS-
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free OVA-triggered hypodermal infiltration was similar to the one observed in
saline-treated animals (Figures 3.5a-b). Moreover, local MC were not activated
(Figure 3.5c) and S1P and SphK1 mRNA levels remained unaltered following
LPS-Free OVA exposure (Figures 3.5d-e). These results suggest that the LPS
co-administered with OVA Ag participated in the early skin inflammatory
responses. This makes sense as most environmental Ag penetrate the body
likely combined with LPS, thus mimicking natural Ag exposure. Several studies
have investigated the effect of LPS “contamination” of OVA in allergic responses.
While some studies reported that LPS/TLR4 signaling prime pro-inflammatory
responses to OVA (Dong et al., 2009; Eisenbarth et al., 2002), others described
protective effects of LPS in airway allergic responses (Watanabe et al., 2003).
Our study is the first to compare the effects of OVA to LPS-free OVA in a mouse
model of skin inflammation. Furthermore, our results suggest that LPS exposure
may prime initial inflammatory responses, as recently suggested (Yoon et al.,
2016), and promote local MC activation and endogenous S1P production. Of
note, topical exogenous S1P administration attenuated contact dermatitis in a
hapten-induced murine AD-like model (Reines et al., 2009) and topical
application of Fingolimod (FTY720), a structural analog of sphingosine also
phosphorylated by SphK that acts as an S1P receptor agonist, could attenuate
skin inflammation (Sun et al., 2016). Thus, we propose that endogenously
produced S1P can exert varied pro-inflammatory functions, compared to
exogenously applied, anti-inflammatory S1P.
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The small but statistically significant structural and molecular alterations
between saline and OVA treatment were expected, as these pathogenic events
occurred prior to any overt sign of disease. Therefore, these primary and newly
uncovered responses could not be compared to the large differences often
reported when comparing acute to chronic AD skin lesions and further
emphasize the relevance of our findings to pre-symptomatic AD pathogenesis.
These initial signs of skin remodeling set the stage to forthcoming clinical
features of AD, including eczematous lesions observed later in this preclinical
model (after 3 OVA exposures) and in human AD. These findings highlight
perhaps new prophylactic approaches for this disease whose treatment
management still remains a clinical challenge.
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Figure 3.1 Skin remodeling starts after a single epicutaneous exposure to
OVA. (a-b) H&E staining of skin tissues exposed to saline (a) or OVA (b). Panels
a-b are representative images. Original magnification, ×100. (c) Thickness of the
epidermis, dermis and hypodermis layers, as measured in H&E-stained tissues.
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For epidermis thickness, n = 18 (saline, empty bars), 19 (OVA, grey bars), for
dermis, n = 10 and 25 and for hypodermis, n = 10 and 25 individual measurements
collected from 3-5 animals/treatment group/skin layer. (d) Example of H&E stained
skin section focusing on the hypodermis (red arrow, original magnification, ×400)
in which (e) nuclei are color-thresholded (orange) and a fixed circular region of
interest (ROI, black circle) defined. (f) Nuclei numbers per ROI of multiple saline
treated mice, compared to OVAtreated mice. (g) Representative nuclei
enumeration performed in each ROI (n = 25 ROI) throughout the hypodermis of
one saline-treated mouse (empty circles) and of another exposedto OVA (filled
circles). Red symbols refer to blood vessel (Bv)-containing ROI. (h) Infiltration
analysis focusing around Bv. (i) Nuclei within ROI were color-thresholded as in (e)
and enumerated (green). (j) Colored nuclei images were gray-scaled and (k) a
binary image was software-created to calculate the fractal dimension (D) of each
ROI. Panels i-k are representative images of an isolated ROI. (l) D of ROI in skin
specimens treated with saline or OVA. (m) Similar determinations of D were
performed focusing around Bv. For all ROI determinations, 25-30 ROIs/image, a
minimum of twelve 40x-images/skisection; 4 skin sections/2 mice/treatment group
were analyzed (f, h, l, m). Statistical differences were determined with unpaired 2tailed Student’s t test with Welch’s correction. Bar = 50 µm. *p = 0.0142, *** p =
0.0004, **** P≤0.0001.
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Figure 3.2 Chemokines are up-regulated after a single exposure to OVA. (a)
CCL2, CCL3 and CCL5 mRNA levels in OVA-treated skin samples (grey bars),
normalized to those in saline treated skins (empty bars) and quantified against
GAPDH mRNA levels, n = 6 saline animals, 4-5 OVA animals with duplicate
determinations. (b) CCL2 (* p = 0.0383) and (c) CCL3 protein levels in skin extracts
(* p = 0.0356) (b, c) or serum (d, e: * p = 0.0255) and (f) serum CCL5 protein levels
(* p = 0.0307) all collected from mice treated with saline or OVA. Protein
determinations, n = 4 (saline) and 6 (OVA) with duplicate determinations.
Statistical differences were determined with unpaired 2-tailed Student’s t test with
Welch’s correction (a-f). *p ≤0.05, **p ≤0.01, except otherwise indicated; ns, not
significant.
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Figure 3.3 Mast cells degranulation and S1P levels increase in OVA-treated
skin tissues. (a) Alpha chain for the high-affinity receptor for IgE mRNA levels in
OVA-treated samples (grey bars), normalized to saline (empty bars) treated
samples and GAPDH, n = 4 saline animals, 6 OVA animals with duplicate
determinations (*** p = 0.0002). (b, c) Methylene blue-stained skin sections after
saline (b) or OVA (c) treatment. Arrows and inserts show examples of intact (green)
or degranulated (red) mast cells (MC). Panels b-c are representative images. Bar
= 50 µm. (d) Percent MC degranulation determinations in saline- and OVA-treated
samples (* p = 0.0352, fifty 40x- total images/310-485 total MC; 4 skin sections/2
mice/treatment group). (e) Determinations of total serum IgE after one saline or
OVA treatment (1 Patch), n = 6 animals/treatment group, averages of duplicate
determinations and after three saline or OVA treatments (3 Patches), n = 9
animals/treatment group, averages of duplicate determinations (*** p = 0.0001). (f)
Sphingosine-1-phosphate (S1P) content of mouse skins after saline or OVA
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treatment, n = 8 saline and 5 OVA samples. ** p = 0.0088 (g) Sphingosine kinase
(SphK)1 mRNA levels in OVA-treated samples (n = 4), normalized to saline (n =
3) with duplicate measurements (* p = 0.0152). Statistical differences were
determined with unpaired 2-tailed Student’s t test with Welch’s correction.
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Figure 3.4 Skin remodeling and chemokine expression are mitigated in mice
deficient for SphK1 or mast cells: S1P-mediated skin mast cell degranulation
and mast cell-dependent local S1P production. Thickness of the epidermis,
dermis and hypodermis layers in SphK1 KO mice (vertical line patterns) measured
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in H&E-stained skin tissues. For epidermis thickness, n = 15 (saline, white bars),
15 (OVA, grey bars), for dermis, n = 15 and 13 and for hypodermis, n = 15 and 15
individual measurements collected from 3 animals/treatment group/skin layer. (b)
Nuclei numbers per ROI within the hypodermis of saline-treated, compared to
OVA-treated SphK1 KO mice. (c) Nuclei numbers per perivascular ROIs after
saline or OVA treatment (d) CCL2, CCL3, CCL5 and FcεRIα mRNA expression in
OVA-treated (n = 3-4) compared to saline-treated (n = 4) SphK1 KO skins,
normalized to GAPDH, with duplicate determinations. (e) Percent mast cell
degranulation measured in MB-stained saline- or OVA-treated SphK1-KO mouse
skin samples. (f) Thickness of the epidermis, dermis and hypodermis layers of
KitW-sh/W-sh mice (side-patterned bars), measured in H&E-stained tissues (n =
13-15 saline (white), 10-15 OVA (grey) individual measurements collected from 3
animals/treatment group/skin layer. (g) Nuclei numbers per ROI within the
hypodermis of saline-treated compared to OVA-treated KitW-sh/W-sh mice. (h)
Nuclei numbers around perivascular ROIs. (i) CCL2, CCL3, CCL5, FcεRIα and
SphK1 mRNA expression from OVA-treated normalized to saline-treated KitWsh/W-sh mouse skin samples, and to GAPDH, with duplicate determinations. (j)
S1P content of KitW-sh/W-sh mouse skins after saline or OVA treatment (n = 4
mice/experimental group). All measurements were conducted as described in
Figures 3.1-3.3. Statistical differences were determined with unpaired 2-tailed
Student’s t test with Welch’s correction (a-j). **** p < 0.0001.
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Figure 3.5 Cellular infiltration, mast cell degranulation and S1P increase are
abated in mouse back skins exposed to LPS-free OVA. (a) Nuclei numbers per
ROI within the hypodermis of saline (empty bars)-treated compared to LPS-free
OVA (horizontal-patterned grey bars)-treated mice. (b) Nuclei numbers per
perivascular ROIs after saline and LPS-free OVA treatments. (a, b) 20 ROI/animal,
3 mice/treatment. (c) Skin mast cell degranulation (%) measured in MB-stained
saline- or LPS-free OVA-treated mouse skin samples. (d) S1P content of mouse
skins after saline or OVA treatment. (c, d) n = 8 (saline), n = 12 (LPS-free OVA).
(e) Skin SphK1 mRNA expression from LPS-OVA-treated (n = 6) normalized to
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saline-treated (n = 6) mouse skin samples, and to GAPDH, with duplicate
determinations. Statistical differences were determined with unpaired 2-tailed
Student’s t test with Welch’s correction (a-e). All measurements were conducted
as described in Figures 3.1-3.3.
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Table 3.1 Mouse qPCR primer sequences
Target

Forward sequence

Reverse sequence

Mu_Gapdh

CAGAAGGGGCGGAGATGAT

AGGCCGGTGCTGCTGAGTATGTC

Mu_Ccl2

CACTCACCTGCTGCTACTCA

GCTTGGTGACAAAAACTACAGC

Mu_Ccl3

GCCATATGGAGCTGACACCC

TAGTCAGGAAAATGACACCTGGC

Mu_Ccl5

TGCCCTCACCATCATCCTCACT

GGCGGTTCCTTCGAGTGACA

Mu_SphK1

CGTGGACCTCGAGAGTGAGAA

AGGCTTGCTAGGCGAAAGAAG

Mu_FcεRIα

ATTGTGAGTGCCACCGTTCA

GCAGCCAATCTTGCGTTACA
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CHAPTER 4: A MAST CELL-MEDIATED ELEVATION OF CERAMIDES
TRIGGERS APOPTOSIS IN PRE-LESIONAL ATOPIC DERMATITIS.3
4.1 INTRODUCTION
Atopic dermatitis (AD), also known as eczema, is one of the most common
chronic diseases, featuring severe itch and skin lesions. AD affects one-fifth of
individuals residing in developed countries (Weidinger and Novak, 2016). It is
well established that a disrupted skin barrier plays an integral role in AD etiology.
The stratum corneum (SC) is the outermost layer of the epidermis that prevents
water loss and protects underlying tissues from external factors including
allergens and pathogens. It comprises a lipid matrix of cholesterol, free fatty
acids and ceramides (CER) (Elias, 2014; Janssens et al., 2012; Skolová et al.,
2014; van Smeden et al., 2011).
CER are the most abundant SC lipids and play a critical role in
maintaining homeostatic skin functions. Composed of a sphingoid base linked to
a fatty acid chain, CER can be produced by three distinct pathways: the de novo
synthesis pathway requires serine palmitoyl transferase and ceramide synthases
(CerS) to generate CER, the salvage pathway involves degradation of complex
sphingolipids to form CER, and subsequently sphingosine and sphingosine-1

Wedman P., Chumanevich A.P., Aladhami A., Castleberry K.M., Enos R.T., Gandy K.A.,
Velazquez K.T., Murphy E.A., Fuseler J.W., Nagarkatti M. and Oskeritzian C. A.. 2017. A
Mast Cell-Mediated Elevation of Ceramides Triggers Apoptosis in Pre-Lesional Atopic
Dermatitis. To be submitted to J Lipid Res.
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phosphate (S1P), by ceramidases and lastly the sphingomyelin pathway which
generates CER from sphingomyelin and sphingomyelinases (Aflaki et al., 2012;
Grösch et al., 2012; Seumois et al., 2007). CER regulate a variety of
cellularresponses including cell cycle arrest and apoptosis with specific behaviors
being attributed to fatty acid chain length. CER are classified as short, long or
very long chain, based on the number of carbons (C) they feature, C16-C24
being the most common chain lengths (Seumois et al., 2007). Recent studies
have highlighted the importance of CER chain length in skin barrier dysfunction,
highlighting a decrease in very long chain C24 at the expense of long-chain C16
during the chronic phase of AD (Janssens et al., 2012; Park et al., 2012).
However, the status of CER during the early phase of AD has not yet been
explored.
In the current study, we investigated the pre-lesional CER composition of
skin using a variation of a human-AD like mouse model after one 7-day exposure
to Ovalbumin (OVA) or saline (vehicle control) to study disease initiation, the full
model requiring 3 OVA exposures to induce chronic AD and skin lesions (Spergel
et al., 1998). We found that EC OVA treatment of mouse skin resulted in
significantly increased total CER levels, compared to saline controls. In
particular, levels of C16 and C24 CER species were increased in OVA-treated
samples. Elevated CER result from increased synthesis and/or decreased
catabolism. Therefore, local mRNA expression of CER synthase (CerS) and
ceramidase (Asah1/Asah2) was evaluated. CerS 4,5 and 6 but also Asah1
mRNA levels were statistically augmented following OVA exposure. Given the
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overall pro-apoptotic nature of CER, in situ activation of Caspase 3, the
executioner Caspase of apoptosis, was measured using a novel image analysis
method we describe to quantify cleaved Caspase-3 (Casp3) in treated skin
sections, and validated by protein analysis. Since apoptosis may occur as a
result of endoplasmic reticulum (ER) stress, skin samples were further
interrogated for key molecules of ER stress-induced apoptosis.
Mast cells (MC), skin-resident cells located near blood vessels, are wellknown key players in the initiation of atopic diseases and an established source
of a variety of pro-inflammatory mediators secreted upon activation by many
stimuli (Galli and Tsai, 2012; Oskeritzian et al., 2008; Oskeritzian et al., 2015;
Oskeritzian et al., 2010). To substantiate the importance of MC in these
processes, the AD model was repeated in MC-deficient Kit Wsh/Wsh mice. The
absence of MC prevented OVA-induced CER increase and local apoptosis.
Moreover, primary mouse bone marrow-derived MC (BMMC) activated by
exogenous S1P at different time-points in vitro exhibited elevation of CER C16
and C24 species with corresponding increased gene expression of CerS 4,5 and
6 and Asah1. We propose that the MC/CER axis is an essential pathogenic
feature of pre-lesional AD. Targeting this axis may prevent disease development.

4.2 MATERIALS AND METHODS
Atopic dermatitis model
AD was induced female C57Bl/6J mice as previously described (Section
3.2). Mice were purchased from Charles River NCI (Frederick, MD) and The
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Jackson Laboratory (Bar Harbor, ME). Animal experiments were approved and
performed in accordance with IACUC guidelines.
Lipidomics
Lipids were extracted from snap-frozen skin tissues, as described in
section 3.2, and S1P-activated BMMCs. CER were measured, and normalized to
weight of skin sample or per 106 BMMCs.
Quantitative Real-Time qPCR
RNA was extracted from patched skin tissue, cDNA was synthesized and
qPCR preformed as described in section 3.2. The primer sequences (Thermo
Fisher Scientific) used for real-time qPCR amplification are located in table 4.1.
Data were analyzed with CFX Manager™ Software and are normalized
expression to saline-treated samples for in vivo experiments or 0 hour S1P
activation for in vitro experiments and directly proportional to the amount mRNA
of the target gene relative to the amount of mRNA of the reference gene, GAPDH
mRNA levels.
Immunofluorescent quantification of cleaved Caspase-3
Skin tissues collected from euthanized mice were fixed in 4%
paraformaldehyde, paraffin-embedded, sectioned (4 μm thickness) and mounted
on microscope slides. Tissues underwent dewaxing, rehydration, antigen
retrieval, blocking and permeabilization prior to overnight incubation with anticleaved Caspase-3 antibody (CST, Danvers, MA). Secondary AlexaFluor 488
donkey anti-rabbit IgG antibody (Jackson ImmunoResearch, West Grove, PA)
was used to visualize cleaved Caspase-3. Images ((40x) magnification) were
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collected as TIFF files and analyzed. Morphometric parameters were measured
using the MetaMorph® 6.1 Image Analysis software (Molecular Devices,
Sunnyvale, CA) as previously reported by our laboratory (Wedman et al., 2015),
and adapted to quantify cleaved Casp3.
Western blots
Proteins were extracted from snap-frozen skin tissues and the Bradford
protein assay was used to measure concentration. Equal concentrations of
protein were electrophoretically separated on a 4-20% Mini-PROTEAN®TGXTM
gel (Bio-Rad, Hercules, CA) followed by electrophoretic transfer to a
polyvinylidene difluoride (PVDF) membrane. Membranes were incubated
overnight with primary antibodies (Cleaved Caspase-3, CHOP, BiP and GAPDH;
CST, Danvers, MA). Proteins were detected using an HRP-linked secondary
antibody and captured on film. Signal was quantified using ImageJ software
(NIH).
Culture and activation of bone marrow-derived mast cells
Mouse BMMC were generated from progenitors isolated from femurs and
cultured in RPMI 1640 medium (Invitrogen Life Technologies, Carlsbad, CA)
containing 10% heat-inactivated FBS, 2 mM L-glutamine, 1% antibiotics, 1 mM
sodium pyruvate, 1 mM HEPES (Biofluids, Rockville, MD), 2 ng/ml recombinant
IL-3 and 20 ng/ml of stem cell factor (SCF, PeproTech, Rocky Hill, NJ). After 4
weeks of culture, BMMC were more than 98% pure and fully matured. S1P (100
nM) was used to stimulate BMMCs for lipidomics and qPCR analyses.
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Engraftment of MC-deficient mouse skin with BMMC
Mature BMMC, generated from C57Bl/6 mice, were counted and
resuspended in PBS (4 x 106 cells in 400 μl). BMMC were injected intradermally
into back skin of anesthetized mice (8 x 50 μl injections in two rows down the
length of the shaved back) (Kalesnikoff and Galli, 2011). Experiments were
initiated 9 weeks after adoptive transfer of BMMC, allowing for proper
reconstitution of skin MC.
Statistics
Data are expressed as means + SEM (unless otherwise stated) and were
analyzed by using the unpaired 2-tailed Student t test, with Welch’s correction for
samples of unequal variance or nonparametric Mann Whitney test (Prism 6;
GraphPad Software, La Jolla, CA).

4.3 RESULTS
In atopic dermatitis, a single OVA exposure triggers an increase in
ceramides.
CER, the most abundant skin lipids, are known to be decreased in the SC
during chronic AD, resulting in increased dryness and exposure to external
environment (Park et al., 2013). We have recently shown that localized changes
occur very early in response to allergic stimuli (Oskeritzian et al., 2015), thus we
sought to investigate the status of CER at AD onset. Figure 4.1a shows that a
single 7-day EC OVA exposure promoted CER production compared to salinetreated controls. Pertinent CER species were highlighted upon CER profiling,
with CER C16 and C24 species being most augmented (Fig. 4.1b). To determine
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if the accumulated CER were produced de novo, we explored the gene
expression of ceramide synthases (CerS). Figure 4.1c shows increased detection
of CerS 4,5 and 6 but not CerS 1 or 2 mRNA in OVA-treated mice compared to
Saline, normalized to Gapdh (black line). We also observed increased gene
expression for the acid ceramidase, Asah1, but not the neutral ceramidase
Asah2 (Fig. 4.1d). These results suggest that early accrual of CER C16 and C24
stems from both synthetic and catabolic pathways.
OVA exposure leads to increased detection of cleaved Caspase 3
De novo production of C16 and C24 species has previously been linked to
apoptosis in neutrophils (Seumois et al., 2007). Therefore, we next examined
skin tissue sections for cleaved Casp3. Figure 4.2a shows a representative
image of a fluorescently-labeled OVA-treated skin section. Using image analysis
software, line scans were applied to detect positive signal while eliminating autofluorescence (Fig. 4.2b and c). We have recently shown that morphometric
parameters can be applied to quantify cellular changes in situ (Wedman et al.,
2015). Similarly, we established specific parameters for the quantification of
cleaved Casp3 fluorescence. In figure 4.2d, we show that the computer proceeds
with thresholding of positive signal and measurement (in green) while
simultaneously eliminating background staining (orange). By measuring the ratio
of integrative optical density (IOD) over the total image area, we show a
significant increase in cleaved Casp3 following OVA exposure compared to
saline-treated animals (Fig. 4.2e). Presence of increased cleaved Casp3 was
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further confirmed through Western blot analysis and quantification (Fig. 4.2f and
g).
ER-stress contributes to local apoptosis following OVA exposure
Caspase 3, executioner enzyme of apoptosis, can be activated
downstream of intrinsic signaling pathways during cellular stress. De novo
synthesis of CER, by CerS, occurs within the ER (Futerman and Riezman, 2005)
and increased production can trigger ER stress (Longato et al., 2012). To
determine if CER-induced apoptosis results from ER stress, we examined the
skin tissues for stress-related markers. Local mRNA levels of binding
immunoglobulin protein (BiP), activating transcription factor 4 (Atf4), x-box
binding protein 1 (Xbp-1) and C/EBP-homologous protein (Chop) were all
augmented following OVA exposure (Fig. 4.3a). Furthermore, significantly more
CHOP (but not BiP) was detected by Western blot in OVA-treated skins
compared to saline alone (Fig. 4.3b-d).
OVA-induced increase in ceramides C16 and C24, and resulting apoptosis,
is dependent on mast cells
To substantiate how MC could contribute to ceramide regulation in vivo,
we repeated similar experiments in MC-deficient KitW-sh/W-sh mice. Here we show
that in the absence of MC, OVA exposure did not lead to ceramide accumulation
(Fig. 4.4a and b) or changes in localized gene expression seen in WT mice
(Fig.4.1c and d) for CerS 4, 5 and 6 or ceramidases (Asah 1 and Asah 2), in MCdeficient KitW-sh/W-sh mice (Fig. 4.4c and d). Furthermore, no change in cleaved
Casp3 was measured upon OVA treatment (Fig. 4.4e and f) in KitW-sh/W-sh mice.
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To further confirm the importance of MC in CER-driven apoptosis, skin of KitWsh/W-sh

mice was reconstituted through adoptive transfer of BMMC. Reconstituted

mice were similarly treated with OVA and saline, as a control. Figures 4.4g and h
show that protein production of cleaved Casp3 and CHOP was restored in OVAtreated reconstituted mice.
Bone marrow-derived MC, activated in vitro by sphingosine-1-phosphate,
display a CER profile comparable to OVA-treated WT mice skin samples
We recently highlighted the importance of S1P activation of MC in an
acute pulmonary model of allergic response (Oskeritzian et al., 2015). Since we
demonstrated that MC are required for early CER changes in the skin following
OVA exposure, we next investigated if exogenous S1P would also trigger CER
production in MC. In figure 4.5, BMMC were in vitro stimulated with S1P at
different time points. Total CER were measured (Fig. 4.5a) and CER profiling
was conducted (Fig. 4.5b) at 0, 6 and 16 hours following S1P activation. Total
CER levels were time-dependently increased with CER C16, C22 and C24
species being most prominent after 16 hours of stimulation. Further interrogation
of BMMC showed increased gene expression of Cers 2, 4, 5 and 6 (Fig. 4.5c)
and ceramidase Asah 1 (Fig. 4.5d) 3 hours following S1P stimulation,
recapitulating the findings in mouse skin samples for the most part.

4.4 DISCUSSION
Ceramides are well known to play a role in chronic AD, but their function
at AD onset is still unclear. Here, we report that ceramide accumulation can be
observed in pre-lesional skin samples very early following a 7-day exposure to
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OVA, compared to saline controls. OVA exposure resulted in significant elevation
of total ceramides in particular, C16:0, C24:0 and C24:1 species. A recent study,
conducted by YH Park et al., reported increased C16:0 at the expense of C24
species in a preclinical model of chronic AD (Park et al., 2012). However, it is
important to note that 1) they extracted lipids from the SC layer only, and 2) mice
had skin lesions, which are absent in our 7-day model. While ceramides are
generally considered to be pro-apoptotic, it has been shown that C24 species
can have protective effects (Grösch et al., 2012). As both pro-apoptotic C16
(Mullen et al., 2011) and protective C24 species accumulated following one week
OVA exposure, it is tempting to speculate that pro-survival mechanisms were in
effect to return to homeostatic conditions. Of note, accumulation of both C16 and
C24 ceramides has been observed within malignant tumors of head and neck
squamous cell carcinoma and breast cancer patients compared with normal
and/or benign tumor tissues, suggesting that the balance between C16 and C24
species may control both apoptotic and survival pathways (Karahatay et al.,
2007; Schiffmann et al., 2009).
In addition to increased ceramide levels, an increase in mRNA expression
for ceramide-generating enzymes was also observed. Ceramide synthases
(CerS) 1-6 link specific subsets of fatty acyl-CoAs to a sphingoid base generating
ceramides with varying chain lengths, while ceramidases (acidic, neutral and
alkaline) catalyze the cleavage of ceramides. Here we show increased
expression of CerS 4,5 and 6. It has previously been shown that CerS 5 and 6
are specific for long chain ceramides, including C16. CerS 4, the least studied
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CerS, is considered to be a broad-spectrum CerS. Expression of CerS 4 has
previously been linked to increased C24 ceramide species (Mizutani et al., 2009).
Tirodkar et al. recently reported that elevation of CerS6 could mediate
transcriptional activation of Asah1, which could explain the increased detection of
acid ceramidase we observed following OVA exposure (Tirodkar et al., 2015).
In this study, we report that topical OVA exposure induces an increase in
C16 and C24 ceramide species compared to saline-exposed controls. Previous
studies have linked de novo generation of C16 and C24 ceramides to
spontaneous neutrophil apoptosis (Seumois et al., 2007) and tumor-induced DC
apoptosis (Kanto et al., 2001). Similarly, we report that substantially increased
C16 and C24 ceramides was linked to apoptosis, as measured by
immunofluorescence staining of mouse skin sections upon OVA treatment.
Detection of cleaved Casp3 was further validated and confirmed through
quantification of cleaved Casp3 protein in OVA compared to saline-exposed skin
samples using Western blot analysis. Thus, it appears the pro-apoptotic effects
of C16 surpass protective C24 at the initiation of AD.
When injury occurs, the ER stress response initiates survival pathways.
The chaperone protein, BiP, dissociates from IREI, ATF6 and PERK activating
the unfolded protein response (UPR). If the UPR fails, the ER-stress apoptosis
pathway initiates, involving CHOP and the Caspase cascade (Chang et al.,
2013). Our results indicated BiP and transcription factors Atf4, Xbp1 and Chop,
were increased in skin samples following OVA application, with confirmed
elevation of CHOP protein, key mediator of ER stress-induced apoptosis.
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We have shown the importance of MC during early allergic lung
inflammation (Oskeritzian et al., 2015). Thus, we sought to investigate if MC were
contributing to the augmentation of ceramides during early skin inflammation. In
MC-deficient KitW-sh/W-sh mice, OVA application did not trigger ceramide elevation
and cell survival was evident in the absence of cleaved Casp3. However,
following MC reconstitution, cleaved Casp 3 levels returned to WT levels, also
downstream of CHOP. Furthermore, we discovered that in vitro S1P activation of
mouse BMMC stimulated ceramide production pathways leading to a comparable
ceramide profile to the one observed in OVA-exposed WT mice skin samples.
In conclusion, targeting S1P/MC interactions may be a novel prophylactic
approach to prevent ceramide-mediated apoptosis at the onset of AD.
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Figure 4.1 Skin exposure to OVA leads to increased ceramides in WT mice.
A single, 7-day, OVA exposure resulted in elevation of total ceramides (a).
Further analysis revealed specific increases in C16 and C24 ceramide species in
OVA- compared to saline-treated mice (b). Elevated levels of mRNA for ceramide
synthases (CerS) 4, 5 and 6 (c) and acid ceramidase (Asah1) (d) were observed
in response to OVA.
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Figure 4.2 Increased cleaved Caspase 3 is observed following OVA
exposure. Cleaved capase-3 (Casp3) signal was analyzed in fluorescently
labeled skin sections using a line scan histogram (a-c) and integrative optical
density (IOD), which represents the mass or total amount of the fluorescent
signal. Applying these parameters, images were thresholded to measure positive
signal (d1, green). Significantly more cleaved Casp3 was quantified in situ in
OVA-treated skins compared to saline (e). Protein analysis further confirmed
production of cleaved Caspase 3 in OVA-treated skin samples (f-g).
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Figure 4.3 OVA treatment leads to endoplasmic reticulum stress-induced
apoptosis. Gene expression of key ER-stress regulators was upregulated
following OVA treatment (a). A significant increase in Chop protein (b, n = 6
mice/treatment group, c), but not Bip (b, d) was observed following OVA
exposure.
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Figure 4.4 Ceramides, mRNA coding for genes involved in ceramide
production remain unaltered and apoptosis undetectable upon OVA
treatment of KitW-sh/W-sh MC-deficient mice. In the absence of MC, OVA
exposure did not generate an increase in total ceramide levels (a), or in any
specific ceramide species (b). The increased levels of mRNA for CerS 4, 5 and 6
and Asah 1, seen in WT mice treated with OVA (Fig. 4.1c, d), were unchanged in
similarly treated MC-deficient KitW-sh/W-sh mouse skin samples (c, d). Western blot
band quantification (f) showed no difference in Casp3 cleavage in OVA- or
saline-treated MC-deficient KitW-sh/W-sh samples (e, n = 4 mice/each treatment
group). Casp3 activation was restored in OVA-treated KitW-sh/W-sh following MC
reconstitution (g), concomitant with increased production of CHOP protein (h).
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Figure 4.5 In vitro S1P stimulation triggers ceramide generation in BMMC.
Increased production of total CER is observed after 16 hours of BMMC activation
by S1P (a). Profiling highlights elevation of CER C16 and C24 species, also
observed following OVA exposure in vivo (b and Fig. 4.1). Gene expression was
significantly higher for CerS 2, 4, 5, 6 and Asah1 after 3 hours of S1P stimulation
compared to untreated BMMC (c, d).
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Table 4.1 Mouse qPCR primer sequences
Target

Forward sequence

Reverse sequence

Mu_Gapdh

CAGAAGGGGCGGAGATGAT

AGGCCGGTGCTGCTGAGTATGTC

Mu_Cers1

CCACCACACACATCTTTCGG

GGAGCAGGTAAGCGCAGTAG

Mu_Cers2

ATGCTCCAGACCTTGTATGACT

CTGAGGCTTTGGCATAGACAC

Mu_Cers4

TACCCACATCAGACCCTGAAT

TGAAGTCCTTGCGTTTGACATC

Mu_Cers5

CGGGGAAAGGTGTCTAAGGAT

GTTCATGCAGTTGGCACCATT

Mu_Cers6

ATTCAACGCTGGTTTCGACAA

TTCAAGAACCGGACTCCGTAG

Mu_Asah1

CACCAGCGTTGAGGATTTTAGT

TACCAGGCAGCTTTTGATCCA

Mu_Asah2

GCAAAGCGAACCTTCTCCAC

ACTGGTAACAAACAAGAGGGTGA

Mu_Casp3

ATGGAGAACAACAAAACCTCAGT

TTGCTCCCATGTATGGTCTTTAC

Mu_Atf4

GGGTTCTGTCTTCCACTCCA

AAGCAGCAGAGTCAGGCTTTC

Mu_Chop

CCACCACACCTGAAAGCAGAA

AGGTGAAAGGCAGGGACTCA

Mu_Bip

TTCAGCCAATTATCAGCAAACTCT

TTTTCTGATGTATCCTCTTCACCAGT

Mu_Xbp1

GAACCAGGAGTTAAGAACACG

AGGCAACAGTGTCAGAGTCC
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CHAPTER 5: A MIRNA TRIAD EPIGENETICALLY REGULATES AD
PATHOGENESIS 4
5.1 INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease relieved by
symptom management but with no cure. Skin-resident MC express many
receptors, including the high affinity receptor for IgE (FcεRI) (Galli et al., 2008),
which once cross-linked with Ag, initiates MC secretion of inflammatory
histamine, cytokines and chemokines, many of which are pre-formed. IgE
crosslinking also results in SphK1 activation, leading to the production of S1P, a
multifunctional sphingolipid metabolite endowed with proinflammatory and
chemotactic properties (Olivera et al., 2006; Oskeritzian et al., 2008). Once
exported out of MC, S1P can ligate MC-expressed S1P receptors (S1PR) (Mitra
et al., 2006; Oskeritzian et al., 2008; Oskeritzian et al., 2007). S1PR2 signaling
amplifies local allergic responses through further MC stimulation and immune cell
recruitment (Oskeritzian et al., 2015). We recently discovered that S1P ligation of
S1PR2 on MC was a key driver of early inflammatory pathways in acutely
inflamed lungs. Moreover, these studies identified a new MC-associated
signaling pathway that encompasses activation of signal transducer and activator
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of transcription 3 (Stat3) downstream of S1P/S1PR2, critical to MC-derived
chemokine secretion (Oskeritzian et al., 2015).
In recent decades, increased prevalence of AD was observed in
developed countries. While research has identified genetic inheritability as one
factor that contributes to AD manifestation, the rise in affected individuals cannot
be attributed to genetic factors alone. With the discovery of miRNA, short noncoding RNA that can post-transcriptionally modify gene expression, new studies
began to investigate the epigenetic regulation of AD. Such studies have focused
on miRNA expressed in psoriasis and established AD (Sonkoly et al., 2007),
while others have investigated that status of miRNA in skin (Sonkoly et al., 2010)
and keratinocytes (Rebane et al., 2014) of AD patients bearing chronic lesions
compared to healthy controls. However, miRNA alterations at the pre-lesional
phase of AD has yet to be explored.
We employed a well-established preclinical model that mimics human ADlike disease progression and consists in three 1-week EC exposures to OVA,
each separated by two weeks of rest (Spergel et al., 1998). We discovered that
miRNA 34a, 485 and 486 were consistently down-regulated in skin samples
exposed three times to OVA compared to saline-treated skins. In silico analysis
of predicted target genes and pathways identified canonical cytokines and
chemokines associated with AD anticipated to be de-repressed by decreased
expression of these miRNA. Interestingly, SphK1 and Stat3 were also highlighted
as target genes predicted to be up-regulated.
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To investigate the relevance of this newly identified miRNA triad to AD
pathogenesis, miRNA profiling was also performed on skin samples collected
following a single OVA or saline exposure. Surprisingly, we observed that
miRNA-34a, 485 and 486 were also significantly down-regulated at the early
stage of AD, further highlighting their implications in disease development.

5.2 MATERIALS AND METHODS
Mice
Aged- and gender-matched C57Bl/6 mice were shaved on the back and
skin was tape-stripped prior to OVA or saline exposure, as previously described
(Chapter 3) (Spergel et al., 1998). Skin samples were collected following the first
and third exposures.
RNA extraction
Snap-frozen skin samples were homogenized and RNA was extracted
using Qiagen miRNeasy kits, according to manufacturer’s instructions.
MicroRNA expression profiling
RNA samples collected following three exposures were sent to Johns
Hopkins University Deep Sequencing and Microarray core (Baltimore, MD) for
miRNA microarray analysis, using the Affimetrix Genechip MiRNA 3.0 array
platform and oligonucleotide probe sets for 1,111 mouse mature MiRNAs from
Sanger miRbase. Four skin samples were analyzed from two OVA-treated and
two saline-treated mice (n= two independent experiments). MiRNA microarray
profiling of RNA collected at AD onset (i.e. following a single exposure to OVA or
saline) was conducted using the Affimetrix GeneChip miRNA 4.0 platform with
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oligo probe sets for ~3,200 mouse miR (n=three independent experiments – OVA
compared to saline) at the Microarray Core Facility, SC College of Pharmacy at
USC Columbia.
Computational pathway analysis
Ingenuity Pathway Analysis (IPA) software (Ingenuity ® Systems) was
used to identify target genes and pathways regulated by differentially expressed
miRNA.
Real time qPCR
Total skin RNA were reverse transcribed to obtain cDNA using iScript
synthesis kit (Bio-Rad). QPCR was completed using SensiFAST SYBR No-ROX
kit (Bioline) on Bio-Rad CFX connect platform (see primer sequences in Table
5.1). To validate the miRNA microarray analysis, cDNA generated with the
miScript II RT Kit was used as a template for qPCR with the miScript SYBR
Green PCR Kit and miScript Primer Assays, according to manufacturer’s
instruction (Qiagen).

5.3 RESULTS
Skin miRNA profiles following repeated exposure to OVA
In a preclinical model of AD consisting in repeated EC exposure to OVA or
saline (controls) (Spergel et al., 1998), we identified, by miRNA microarray
analysis, a triad of miRNA consistently down-regulated following OVA exposure:
miR 34a, 485 and 486 (Figure 5.1a). Figure 5.1b shows qPCR validation of these
miRNA, confirming the significant reduction of expression in OVA-treated
samples compared to saline, after normalization to Small Nucleolar RNA, C/D
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Box 96A (Snord96a) control. Furthermore, analysis of predicted target genes
using bioinformatics computational tools identified canonical mediators
associated with AD, including IgE receptors (FcεRIα and FcεRIγ chains),
cytokines and chemokines (Figure 5.1c), upregulated by decrease of these
miRNA. Further qPCR analysis confirmed increased expression of mRNA
coding for CCL5, FcεRIα, and TNFα (Figure 5.1d). Of note, SphK1 and IL17a
mRNA levels were not significantly altered.
MiRNA profiling of skin following one OVA exposure
Next, we sought to determine the contribution of these miRNA to the
inception of AD as potential disease biomarkers and molecular targets. Figure
5.2a shows the average fold change of miRNA in skin samples collected from 3
independent in vivo experiments when comparing a single 1-week OVA exposure
to saline controls. Mature miRNA may be generated from the 3’ or 5’ arms of premiRNA precursors. To further establish the relevance of this miRNA triad to AD
onset, both 3p/5p miRNA species were investigated. A significant decrease in
miRNA-34a-3p and -486-5p was established by microarray analysis (Figure 5.2a)
that did not reach statistical significance for miRNA-485-5p and -486-3p.
Validation of the microarray data by qPCR established down-regulation of
miRNA-34a-5p, -485-5p, -486-3p and-5p species (Figure 5.2b). Analysis of
predicted target genes revealed significant elevation of FcεRIα, SphK1 and
chemokines CCL5, CCL19, CCL21 and CCL22 (Figure 5.2c).
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5.4 DISCUSSION AND FUTURE DIRECTIONS
Little is known about the epigenetic regulation of AD. Among epigenetic
modifiers, miRNA are small noncoding RNA that influence gene expression by
inhibiting translation or inducing RNA degradation (Sonkoly et al., 2010). Using a
preclinical AD model (Spergel et al., 1998), we discovered that three miRNAs,
34a, 485 and 486 were consistently down-regulated in diseased compared to
healthy skin samples. Moreover, in silico analysis of predicted target genes and
pathways for these miRNA identified canonical cytokines IL-5, IL-17a (Auriemma
et al., 2013) and chemokines CCL19, CCL21 (Kawakami et al., 2009; Millrud et
al., 2014) associated with AD de-repressed by decrease of these miRNA.
Interestingly, SphK1 and Stat3 were also triad-targeted. Because our lab focuses
on unraveling early molecular events driving disease pathogenesis, the status of
our newly discovered miRNA triad was evaluated following a single OVA
exposure compared to saline control. Surprisingly, we found miRNA 34a, 485
and 486 were also significantly down-regulated at AD inception.
Sonkoly et al. reported the overexpression of miRNA-155 in chronic AD
skin lesion compared to healthy human skin (Sonkoly et al., 2010). Interestingly,
they also described down-regulation of miRNA-486 in chronic human skin
lesions. Rebane et al. evaluated miRNA expression in keratinocytes of chronic
AD patients that featured upregulation of miRNA-146a expression. Of interest,
miRNA-34a was also down-regulated in their study (Rebane et al., 2014).
To further assess the functional contribution of these miRNA in vivo,
down-regulation of these miRNA will be induced in saline-treated controls of our
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AD preclinical model, using antisense oligonucleotides, antimiRs acting as
miRNA inhibitors. Locked nucleic acid (LNA) modified oligonucleotides (LNAantimiR, Exiqon, Woburn, MA, compared to LNA-mismatch antimir control) will
be utilized because they allow long-lasting in vivo miRNA inhibition (Stenvang et
al., 2012). We anticipate that forcing down-regulation of these miRNA in control
mice should recapitulate the remodeling, cellular and molecular findings of those
obtained after OVA treatment. To monitor the anti-sense activity and effective
miRNA inhibition, a functional read-out of miRNA silencing is recommended and
will consist in measuring de-repression of direct targets by qPCR and protein
assays (Western blots and ELISA) as an evidence for success. In a
complementary approach, primary mouse and human MC will be transfected with
miScript synthetic miRNA mimics (mimics and HiperFect transfection reagents
from Qiagen) of each member of the miRNA triad separately or in combination.
MC activation with S1P and subsequent chemokine production will be assessed
in vitro and compared to non-transfected MC and MC transfected with mock
mimics. We anticipate that miRNA overexpression will result in MC
hyporesponsiveness.
To our knowledge, the current study is the first to investigate the
epigenetic regulation of early inflammatory events featured in pre-symptomatic
AD. These results highlight an important group of miRNA, downregulated at
disease onset and during chronic-stage skin inflammation. We show that these
miRNA target relevant AD-associated cytokines and chemokines and also
MC/S1P signaling-related FcεRI, SphK1 and Stat3 gene expression. These
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results suggest that the contribution of skin MC-derived chemokines and S1P we
observed at AD initiation (Chapters 3 and 4) may be epigenetically regulated by
miRNA 34a, 485 and 486.
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Figure 5.1 Down-regulation of skin miRNA up-regulates AD-associated
gene expression. A miRNA triad, composed of miRNA 34a, 485 and 486 is
consistently decreased following 3 OVA exposures compared to saline-treated
skin (n = 2 independent trials). Down-regulation of miRNA was validated and
Ingenuity Pathway Analysis (IPA) software (Ingenuity® Systems) was used to
identify predicted target genes, including cytokines and chemokines (pink), FcεRI
receptor sub-units (purple), Sphingosine kinase 1 (SphK1, orange) and
transcription factor Stat3 (red) (b,c). To test the biological relevance of in silico
predictions, qPCR was used to determine the mRNA levels of some of the
predicted target genes in OVA- compared to saline-treated skin samples,
normalized to GAPDH (d).

88

Figure 5.2 A newly identified AD-associated microRNA signature is also
relevant to AD pathogenesis with validated target gene de-repression. To
determine their contribution to AD onset, status of triad members was analyzed
following a single OVA exposure, compared to saline, (n = 3 independent trials)
and validated by qPCR, confirming significant decrease in miR34a-5p, miR4855p, miR486a-3p and -5p (b). Gene expression for some disease-relevant
predicted triad-targets was increased (c).
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Table 5.1 Mouse qPCR primer sequences
Target

Forward sequence

Reverse sequence

Mu_IL17a

GCTCCAGAAGGCCCTCAGACT

CCAGCTTTCCCTCCGCATTGA

Mu_TNFα

CCAGTGTGGGAAGCTGTCTT

AAGCAAAAGAGGAGGCAACA

Mu_Ccl19

GCCTGCTGTTGTGTTCACC

CCTTTGTTCTTGGCAGAAGACT

Mu_Ccl21

TGAGCTATGTGCAAACCCTGAGGA

TGAGGGCTGTGTCTGTTCAGTTCT

Mu_Ccl22

AGGTCCCTATGGTGCCAATGT

CGGCAGGATTTTGAGGTCCA
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CHAPTER 6: SUMMARY AND CONCLUSIONS
6.1 MOLECULAR MECHANISMS UNDERLYING EARLY SKIN REMODELING AT
THE ONSET OF ATOPIC DERMATITIS

In 1998, Spergel et al. published a pre-clinical model of human-like AD.
The model consists of shaving the back of the mouse and securing a patch
containing ovalbumin (OVA, Ag) to the mouse for 3 consecutive 1 -week periods,
each separated by two weeks of rest (Spergel et al., 1998). Our lab is most
interested in investigating disease initiation, so we collected samples after the
first 1-week exposure. Surprisingly, we observed skin thickening and increased
cellular infiltration into the hypodermis during this early phase of inflammation.
Quantitative image analysis revealed a significant increase in hypodermal nuclei
following OVA exposure, most concentrated around blood vessels. Next, local
and systemic levels of CD3+ T-cell recruiting chemokines were evaluated. We
found that OVA-treated skin featured localized augmentation of CCL2, CCL3 and
CCL5, chemokines we previously identified as key players of remodeling in Agchallenged airways (Oskeritzian et al., 2015).

6.2 SPHINGOSINE-1-PHOSPHATE AND MAST CELLS CONTRIBUTE TO SKIN
INFLAMMATION IN EARLY-PHASE ATOPIC DERMATITIS
We conducted the first study that has identified that cellular infiltration
initiated in the highly vascularized hypodermal skin layer. As previously
mentioned, local resident MC reside within close proximity to Bv, allowing them
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to play an active role in cell recruitment following release of chemokines. We
established and published a method to evaluate MC activation status in situ by
taking advantage of the metachromatic properties of methylene blue, which
stains all nuclei blue while distinguishing MC from other cells through binding of
granule-specific peptidoglycans resulting in purple coloration. MC status was
evaluated in skin tissue collected from naïve C57Bl/6 mice and we identified a
spectrum of morphometric parameters that could distinguish resting from
degranulated MC in situ following a computer-assisted procedure. Applying these
parameters to OVA-challenged skin samples highlighted a significant increase in
localized MC degranulation compared to saline controls. MC are canonically
activated through IgE/Ag stimulated pathways. However, we confirmed that a 7day OVA exposure did not elicit augmented levels of total IgE, as Ab production
takes 10-14 days. Moreover, mRNA expression of S1P producing enzyme
SphK1, was significantly increased in skin of OVA-treated mice compared to
saline controls and lipidomics analysis revealed a corresponding increase of
S1P. SphK1 knockout and MC-deficient KitWsh/Wsh mice failed to exhibit skin
remodeling, hypodermal infiltration and associated chemokine production,
following OVA exposure. Moreover, MC-deficient mice did not feature
augmentation of S1P, identifying MC as a local source.
Interestingly, the very group from Harvard who established the AD mouse
model, used by us and many other groups world-wide, recently reported that
tape-stripping, a procedure included in the animal protocol that mimics the
scratching response of human patients, resulted in the release of endogenous
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TLR4 ligands (Yoon et al., 2016). Commercially available OVA is notorious for its
high content of TLR4-binding lipopolysaccharide (LPS). Our study is the first to
compare the effects of OVA to LPS-free OVA in a mouse model of skin
inflammation. Contrary to what we expected, based on a study describing the
protective effects of LPS in airway allergic responses (Watanabe et al., 2003)
and another finding high LPS exposure protected Amish children from high
occurrence of allergic disorders affecting genetically-related Hutterite children
(Hutterites using industrialized more aseptic farming methods compared to
Amish people who use traditional farming methods) (Stein et al., 2016), local MC
activation and S1P production were comparable to saline controls in LPS-free
OVA-treated samples. Of note, other studies have reported pro-inflammatory
responses following LPS/TLR4 signaling (Dong et al., 2009; Eisenbarth et al.,
2002), perhaps due to differences in experimental procedures, timing of
exposure and dose effect. Overall, our results suggest that LPS penetration of
the skin through the compromised barrier may prime initial inflammatory
responses, independently of Ag, as recently suggested (Yoon et al., 2016),

6.3 OVA TRIGGERS MC-RELATED PRODUCTION OF PRO-APOPTOTIC
CERAMIDES AT ATOPIC DERMATITIS ONSET
Ceramides (CER) are the dominant lipid species within skin and have a
key role in skin barrier maintenance. Skin of AD patients displays decreased
levels of very long chain CER. Analysis of CER species, following 7-day OVA
exposure, highlighted augmentation of total skin CER compared to saline
controls. CER profiling indicated that the observed increase was specific to CER
C16 and C24 species. In general, CER are considered pro-apoptotic and further
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investigation revealed increased detection of cleaved Casp3 in OVA-challenged
skin. Further skin analysis revealed localized increase of CHOP, which initiates
the Caspase cascade downstream of ER stress. Surprisingly changes in CER
composition were not observed in OVA-treated MC-deficient KitWsh/Wsh mice, but
were restored following MC reconstitution, indicating a potential role for MC in
CER accumulation. To further investigate this, we activated BMMC in vitro with
S1P, a likely stimulus of MC as we have shown doubling of skin-associated S1P
at the inception of AD in this model. Interestingly we detected a significant
increase in C16 and C24 CER species following a 16-hour activation period.
Furthermore, mRNA expression of ceramide producing enzymes CerS and
ceramidase was increased within 3 hours of S1P stimulation.
Overall, this work features concerted interplay between MC/S1P/CER axis
and early development of AD. These studies highlight MC and S1P as potential
prophylactic targets that could interfere with disease onset and progression.

6.4 DOWN-REGULATION OF MIRNA 34A, 485 AND 486 REGULATES AD
PATHOGENESIS
We report, for the first time, evidence for epigenetic regulation of presymptomatic remodeling in AD using an established mouse human AD-like
model. We found that the skin exposure to Ag OVA triggered the downregulation
of a unique miRNA triad whose predicted gene targets included AD-related
cytokines/chemokines downstream of the MC/S1P signaling pathway. While the
potential ability of these miRNA to regulate cellular infiltration has yet to be
established, their down-regulation was accompanied with a significant increase in
FCεRIα, SphK1 and CCL5 mRNA expression, predicted target genes coding for
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cellular, enzymatic and molecular elements we already proved important to
disease manifestation (Chapter 3).
Sonkoly et al. and Rebane et al. recently conducted miRNA profiling of
human skin lesions and keratinocytes during chronic AD, compared to healthy
controls (Rebane et al., 2014; Sonkoly et al., 2010). Importantly, their studies
also identified down-regulation of miRNA 34a and 486, however without offering
any mechanistic and/or functional insights. We demonstrate that these miRNA
are similarly affected in mice and, more importantly, are affected at AD onset as
well, highlighting their potential as prophylactic targets.
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Figure 6.1 Inflammatory changes occur early after topical application of LPS-containing OVA in an established
mouse human AD-like model. Skin shaving and tape-stripping first expose keratinocytes to LPS-containing OVA. LPS
ligation of TLR4 on keratinocytes (and on MC) may result in S1P secretion that, in turn, can activate MC. MC activation
leads to substantial local elevation of S1P and T cell-attracting chemokine CCL2, CCL3 and CCL5 release, resulting in
cellular infiltration of the vascularized hypodermis. Furthermore, skin lipidomics revealed local increase in apoptosispromoting ceramide (CER) species, due in part to MC. These pre-symptomatic effector mechanisms were epigenetically
regulated by the down-regulation of miRNA 34a, 485 and 486a.
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